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CHAPTER I 
INTRODUCTION 
Hereditary lysosomal S-glucosidase deficiency (Gaucher dis-
ease), an autosomal recessive disorder, is characterized by accumula-
tion of the neutral glycosphingolipid glucosylceramide in the reticulo-
endothelial system--especially spleen, liver and the bone marrow (Brady 
& Barranger, 1983). This lipid abnormality arises due to a deficiency 
of the specific catabolic lysosomal enzyme glucosylceramide:S-gluco-
sidase (glucocerebrosidase) (Brady et al., 1965). Clinically, Gaucher 
disease can be subclassified into three types: type 1 (adult non-
neuronopathic form), type 2 (infantile neuronopathic form) and type 
3 (juvenile subacute neuronopathic form) (Desnick, 1982). 
Although the lipid accumulated in the reticuloendothelial 
system for all three types of Gaucher disease is glucosylceramide, 
the lipid content in cultured human skin fibroblasts from subjects 
with Gaucher disease is somewhat different. In cultured fibroblasts, 
there is not an increased amount of glucosylceramide, but there is a 
higher quantity of the ganglioside sialosylgangliotriaosylceramide 
(GMz) in type 2 Gaucher disease as compared to normal, and sialosyl-
gangliotetraosylceramide (GM1), and disialosylgangliotetraosylceramide 
(GD1a> in type 1 Gaucher disease (Saito & Rosenberg, 1984a,b). At 
this moment, however, it is not known if there are any other lipid 
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2 
abnormalities in cultured human skin fibroblasts from Gaucher disease. 
Since there is alteration of lipid composition in Gaucher 
disease, it might be suspected that there may be alteration in membrane 
fluidity of diseased fibroblast membranes. This alteration in membrane 
fluidity could possibly have a significant role in the pathogenesis 
and pathology of Gaucher disease. Therefore, it is important to under-
stand membrane structure in terms of membrane fluidity. 
Fluidity specifically refers to properties of the hydrophobic 
region of the membrane--in particular the physical state of the fatty 
acyl chains comprising the bilayer structure (Stubbs & Smith, 1984). 
Phenomena relevant to fluidity encompass unsaturation and acyl chain 
length of fatty acids, lateral and rotational mobility of phospho-
lipids, changes in the frequency of trans-gauche isomerization of 
contiguous methylene groups (C-C bonds) in the phospholipid acyl 
chains, changes in the swinging motion of the phospholipid fatty acyl 
chains, changes in phospholipid headgroup conformation, changes in 
interaction of cholesterol with other lipids, and changes in the inter-
action of proteins with lipids (Houslay & Stanley, 1982). 
There are both chemical and physical effectors which can be 
natural modulators of membrane lipid fluidity. The main chemical 
. 
modulators are cholesterol content as compared with phospholipids, 
the degree of unsaturation of phospholipid acyl chains, the content 
of sphingomyelin as compared with phosphatidylcholine, and the content 
of membrane proteins as compared with lipids. The physical effectors 
of lipid fluidity are temperature, pressure, pH, membrane potential 
and Ca2+ concentration (Shinitzky & Yuli, 1982). 
There are several techniques for investigating fluidity of 
biological membranes--including nuclear magnetic resonance (NMR), 
electron spin resonance (ESR), and steady-state fluorescence polariza-
tion. NMR is useful in determining motional characteristics of each 
c-H bond along the acyl chain. ESR gives information on degree of 
disorder in membranes. Steady-state fluorescence polarization gives 
information regarding overall motion of acyl chains adjacent to the 
fluorescent probe (Stubbs & Smith, 1984). Fluorescence polarization 
has several advantages over ESR and NMR in that it can be readily 
applied to complex systems such as biological membranes, the polar-
ized signal is highly sensitive and reproducible, and the data obtained 
are promptly interpretable. It is to be noted, however, that the 
common steady-state approach is an overall average of all membranes 
involved and does not reflect only one aspect of the membranes (Shin-
itzky & Barenholz, 1978). 
A considerable number of fluorescent probes are available for 
fluidity measurements; however, l,6-diphenyl-1,3,5-hexatriene (DPH) 
is the most efficient probe for investigating membrane fluidity of 
biological systems. DPH is a hydrophobic, rigid, elongated molecule 
with cylindrical symmetry (Zannoni et al., 1983). It aligns norm-
ally with its long axis parallel to the lipid chains in the middle 
of the membrane bilayer (Lentz et al., 1976a,b). It has no fluores-
cence signal when in an aqueous environment; however, when incorporated 
into the lipid bilayer, it displays a sharp fluorescence signal 
(Shinitzky & Barenholz, 1974). It is to be noted, again, that DPH 
can only give some average value of fluidity in the heterogenous lipid 
3 
domains present in cell membranes (Shinitzky & Barenholz, 1978). 
Owing to its many useful and well-defined properties, DPH 
has been used to evaluate membrane fluidity, via fluorescence polar-
ization, of a variety of cell membranes. In particular, it has been 
used on cultured human skin fibroblasts from subjects with various 
diseases with interesting results. Using DPH as a probe in whole cells 
or plasma membranes of familial hypercholesterolemia (Haggerty et 
al., 1978), and Duchenne dystrophy plasma membranes (Shaw et al., 
1983), it has been shown that there is an increased fluidity of mem-
branes as compared to matched controls; whereas, whole cells or plasma 
membranes of cultured fibroblasts from Huntington's disease do not 
exhibit any significant difference in membrane fluidity from controls 
(Lakowicz & Sheppard, 1981; Schroeder et al., 1984). Even though 
this technique of determining membrane fluidity has not been used 
considerably in various diseases with membrane lipid abnormalities 
in cultured human skin fibroblasts, it has a useful potential in in-
vestigating inherited metabolic disorders-- especially Gaucher disease. 
It is known that glycosphingolipidsare altered in Gaucher 
disease; however, since glycosphingolipids make up only approximately 
3 percent of total cell membrane lipids (Dawson et al., 1972), they 
possibly do not contribute significantly to the average membrane flu-
idity. The major contributors to the lipid fluidity in membranes 
seem to be cholesterol and phospholipids (Borochov et al., 1977; Cooper 
et al., 1977, 1978; Shinitzky & Barenholz, 1978; Van Blitterswijk et 
al., 1981). It is not known at present whether the content of neutral 
lipids and phospholipids are also altered along with glycosphingolipids 
4 
in cultured skin fibroblasts from subjects with Gaucher disease. 
It is known that cholesterol and phospholipids may be altered 
in red blood cells of patients with Gaucher disease (Balint et al., 
1963). Along with this, there is evidence that phospholipid content 
may be abnormal in Gaucher fibroblasts. When glucosyl (3H) ceramide 
(labeled in sphingosine as well as fatty acid moiety) was administered 
to normal human fibroblasts, it was catabolized, and subsequently, 
(3H) labeled products were found in phospholipids--especially sphingo-
myelin, phosphatidylcholine and phosphatidylethanolamine; whereas, 
in Gaucher cells, this process is greatly reduced (Barton & Rosenberg 
1974). 
Any neutral lipid or phospholipid abnormality in Gaucher dis-
ease would imply that even though there is only a deficiency of one 
enzyme, namely 8-glucocerebrosidase, leading to decreased catabolism 
of glucosylceramide, the metabolic consequences are more widely felt, 
affecting a variety of membrane lipids. Such a finding has not been 
reported and would be of great interest. 
The objective of this dissertation is to evaluate the effect 
of hereditary lysosomal S-glucosidase deficiency in cultured human 
skin fibroblasts on membrane fluidity and correlate this with changes 
in lipid composition. Membrane fluidity in Gaucher disease and in 
normal controls has been evaluated via the technique of steady-state 
fluorescence anisotropy using the fluorescent hydrocarbon probe 1,6-di-
phenyl-1,3,5-hexatriene. In addition, neutral lipid and phospholipid 
composition of fibroblasts were evaluated and correlated with membrane 
fluidity measurements. Attention has been given to cholesterol, 
5 
sphingomyelin and phosphatidylcholine content of normal and diseased 
fibroblasts and their fatty acid composition. The amount of ceramide 
has also been determined in normal and Gaucher diseased fibroblasts. 
The effect of monensin on fibroblast lipids was also investigated 
and correlated in terms of Gaucher disease lipid abnormalities. 
6 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
Gaucher Disease 
Clinical Disease 
Gaucher disease is an autosomal recessive lysosomal disorder 
characterized by deficiency of S-glucocerebrosidase activity with ac-
cumulation of neutral glycosphingolipid glucosylceramide in the reticu-
loendothelial system and possibly brain. Clinically, Gaucher disease 
can be classified into three major types as shown in Table 1 (Desnick 
et al., 1982). Type 1, chronic nonneuronopathic or "adult" form of 
the disease is the most prevalent ( 1/2000 in United States Ashkenazi 
Jews) among patients with Gaucher disease. These patients usually 
exhibit signs of hepatosplenomegaly along with symptoms of thrombo-
cytopenia, anemia, and bone involvement. Of the three types of the 
disease, type 1 is probably least in degree of severity. However, 
in each individual patient, the severity of the disease varies greatly 
along with the age of the individual (Brady & Barranger, 1983). 
Type 2 Gaucher disease, also known as acute neuronopathic 
or "infantile" form of the disease is the most severe in its presenta-
tion. It is usually apparent before six months of age and fatal by 
two years. Not only is there massive hepatosplenomegaly but the 
nervous system is heavily involved--exhibiting muscular hypertonicity 
7 
TABLE 1.--Gaucher Disease--Clinical Subtypes 
Type 1-Non- Type 2-Acute Type 3-Subacute 
Clinical Features Neuronopathic Neuronopathic Neuronopathic 
Clinical onset Childhood/adulthood Infancy Childhood 
Hepatosplenomegaly + + + 
Hematologic complications 
Secondary to hypersplenism + + + 
Skeletal deterioration + + + 
Neurodegenerative course +++ ++ 
Death Variable By 2 yr 2nd-4th decade 
Ethnic predilection Ashkenazi Jewish Panethnic Swedish 
Adapted from Desnick et al., (1982). 
00 
and persistent retroflexion of the head. This form of the disease 
is not restricted to Jewish individuals but is pan-ethnic (Brady & 
Barranger, 1983). 
Type 3 Gaucher disease, also known as subacute neuronopathic 
or "juvenile" form of the disease is also characterized by hepato-
splenomegaly and neurologic involvement. The neurologic damage, how-
ever, occurs later in life and is usually fatal (Brady & Barranger, 
1983). The ethnic predilection seems to be of non-Jewish individuals 
involving Swedish people in particular Norbottnian types (Svennerholm 
et al. , 1982) • 
Pathology and Pathogenesis 
One of the pathognemonics for Gaucher disease is the presence 
of Gaucher cells in the reticuloendothelial system. These are large 
macrophage like cells, having a "wrinkled tissue paper" appearance 
(Brady & Barranger, 1983). Along with the presence of Gaucher cells 
in the reticuloendothelial system, there is a considerable hepato-
splenomegaly encountered in this disease. Along with this, there is 
a frequent skeletal involvement in patients with types 1 and 3 Gaucher 
disease. In types 2 and 3 Gaucher disease, there is extensive neuro-
logic involvements. The cranial nerves and brainstem are heavily 
involved. There is minimal storage of glucocerebroside in ganglion 
cells, but there is loss of neurons, neuronophagia, and deposition 
of this neutral glycolipid in periadventitial cells. 
It seems logical to conclude that most of the pathology that 
arises in Gaucher disease is due to an accumulation of glucosyiceramide 
9 
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in the reticuloendothelial system. It seems, however, that there is 
some accumulation of glucosylsphingosine in the brains of patients with 
Gaucher disease leading to the acute severity of type 2 and type 3 
disease (Nilsson & Svennerholm, 1982). This then could be similar 
to Krabbe's disease in which there is a deficiency of the enzyme 
galactocerebroside:S-galactosidase leading to an increased amount of 
galactosylceramide and the toxic galactosphingosine (Suzuki & Suzuki, 
1983). The involvement of glucosylsphingosine in the pathogenesis 
of Gaucher disease is a very preliminary finding and would have to 
be reconfirmed. 
Diagnosis 
There are several ways to arrive at the diagnosis of Gaucher 
disease once it is suspected in a particular patient. Not only is 
there hepatosplenomegaly and Gaucher cells in the bone marrow aspirates 
but there is elevation of serum nontartarate-inhibitable acid phos-
phatase. The most sensitive method of establishing the diagnosis is 
the measurement of the enzyme S-glucosidase in tissues obtained from 
liver biopsies, cultured amniotic fluid cells, white blood cell prep-
arations or cultured skin fibroblasts (Brady & Barranger, 1983). 
There are various methodologies, utilizing various substrates 
and activators, available to assay the activity of 8-glucosidase. 
The two most widely used substrates are radioactively labeled gluco-
sylceramide and the artificial fluorogenic substrate 4-methylumbel-
liferyl-S-glucoside. The labeled glucosylceramide is the best method 
for diagnosis of the disease; however, 4-methylumbelliferyl-S-glucoside 
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is an inexpensive and efficient way to measure the S-glucosidase activ-
ity (Daniels & Glew, 1982). There are several activators for this 
enzyme which can be used in the assay of S-glucosidase activity--in-
cluding negatively charged phospholipids, gangliosides, sodium tauro-
cholate, Triton X-100, oleic acid and cutscum (Mueller & Rosenberg, 
1977, 1979; Wenger & Olson, 1981; ; Saito et al., 1982; Vaccaro et 
al., 1983). It should be noted that there is reduced activity of 
S-glucosidase in samples obtained from patients with Gaucher disease 
as compared to matched controls. Currently, there is no way to dis-
tinguish the clinical severity of the disease from the enzyme activity 
data (Mueller & Rosenberg, 1979; Wenger & Olson, 1981). 
Properties of S-Glucosidase 
The reaction catalyzed by S-glucosidase for cleaving gluco-
sylceramide into glucose and ceramide is as shown in Figure 1. The 
structural gene for S-glucosidase has been assigned to chromosome 1 
using somatic cell hybridization techniques (Shafit-Zagardo et al., 
1981). Using artificial substrate 4-methylumbelliferyl-S-D-glucoside, 
two major S-glucosidases have been identified--"acid" and "neutral" 
S-glucosidase (Shafit-Zagardo et al., 1980). In cultured human skin 
fibroblasts, there is only the "acid" form of S-glucosidase present 
in the lysosomes. Also, in the various Gaucher subtypes only the 
acid isozyme is deficient in fibroblasts and other organs (Desnick, 
1982). This acid form of S-glucosidase is a lysosomal membrane-bound 
enzyme or is very hydrophobic requiring detergents for optimum activity 
(Mueller & Rosenberg, 1979; Desnick, 1982; Desnick et al., 1982). 
Glucosyl Ceramide 
f3 Cerami de 
I 
Acid f3-Glucosidase 
( Glucocerebrosidase) 
1 
e + I Ceramide I 
Fig. 1. Schematic representation of hydrolysis of gluco-
sylceramide into glucose and ceramide by S-Glucosidase. Adapted from 
Desnick (1982). 
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Using an antibody raised against placental glucocerebrosidase, 
cultured skin fibroblasts have been identified to have two major 
isozymes with molecular weights (Mr) of 63,000 and 56,000 and a minor 
component with Mr of 61,000 (Ginns et al., 1982). In type 1 Gaucher 
disease, the major S-glucosidase isozyme exhibits Mr of 56,000 with 
minor bands occurring at Mr of 63,000 and 61,000. There is cross-
reacting material to Mr of 63,000 in type 3 disease; whereas, there 
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is no crossreacting material found in type 2 Gaucher fibroblasts (Ginns 
et al., 1983). 
There seems to be no difference in the pH optima, and Km values 
of S-glucosidase in Gaucher fibroblasts (all three types) as compared 
to normal cells. However, the Vmax for S-glucosidase from Gaucher 
fibroblasts is decreased as compared to normals (Desnick et al., 1982; 
Saito et al., 1982). Based on inhibitor and activator studies, the 
active site of the enzyme has been proposed to have three components 
(Gatt et al., 1982): 
1. Catalytic site--which recognizes S-glucosyl moiety of its 
substrates and conduritol s-epoxide (an irreversible inhibitor of 
the enzyme). 
2. Substrate binding site--which binds the aglycon moiety of 
inhibitors and substrates. 
3. Hydrophobic site--which can bind lipids and other hydrophobic 
molecules such as phosphatidylserine, glucosylsphingosine and 
taurocholate. 
Ho and O'Brien (1971) and Peters et al. (1977) have also iden-
tified a heat stable, soluble, acidic glycoprotein devoid of S-glu-
cosidase activity as an activator protein for S-glucosidase. 
Lipid Abnormalities 
Glucosylceramide--consisting of sphingosine, a long-chain 
fatty acid, and glucose--is considerably elevated in the reticulo-
endothelial system of patients with Gaucher disease. The amount of 
glucocerebroside in normal human spleens varies between 60-280 µg/gram 
wet weight (Brady & Barranger, 1983). The values in Gaucher spleens 
are considerably raised ranging from 3-40.S mg per gram wet weight. 
Along with increased glucosylceramide, there are increased amounts of 
GM3 but not lactosylceramide in the spleen (Kuske & Rosenberg, 1972). 
The amount of glucosylceramide in brain of Gaucher disease patients 
is somewhat variable. In type 2 disease, there are increased amounts 
of glucosylcermide in gray matter (Sudo, 1977); this lipid is also 
increased in plasma in Gaucher disease (Vance et al., 1969). However, 
there may not be any increased amounts of glycolipids in brains from 
types 1 and 3 patients. 
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The accumulated glucosylceramide in the reticuloendothelial 
system arises from several sources. Erythrocytes, which contain glu-
cosylceramide (GlcCer), lactosylceramide (LacCer), trihexosylceramide 
and globoside, are catabolized via the reticuloendothelial system; 
thereby, originating a source for GlcCer. The turnover of leukocytes 
is the major source of GlcCer along with LacCer (Suzuki, 1982). Also, 
it seems probable that this lipid could also arise from normal cellular 
turnover (Brady & Barranger, 1983). 
Unlike the accumulation of above mentioned lipids in the 
reticuloendothelial system, cultured human skin fibroblasts from 
Gaucher disease have a different lipid accumulation as compared to 
normal fibroblasts. There is a higher quantity of the ganglioside 
sialosylgangliotriaosylceramide (GM2) in type 2 Gaucher disease as 
compared to normal, and sialosylgangliotetraosylceramide (GM1) and 
disialosylgangliotetraosylceramide (GD1a> in type 1 Gaucher disease 
(Saito & Rosenberg, 1984a,b). Along with this, there is evidence that 
phospholipid content may be abnormal in Gaucher fibroblasts. When 
glucosyl (3H) ceramide (labeled in sphingosine as well as fatty acid 
moiety) was administered to normal human fibroblasts, it was catabo-
lized, and subsequently, (3H) labeled products were found in phos-
pholipids--especially sphingomyelin, phosphatidylcholine and phos-
phatidylethanolamine; whereas, in Gaucher cells, this process was 
greatly reduced (Barton & Rosenberg, 1974). Cholesterol levels in a 
Gaucher fibroblast cell line has been determined and there seems to 
be no difference as compared with normal cells (Warren et al., 1976). 
There also seems to be an indication that erythrocyte neutral 
lipid and phospholipids may be altered in Gaucher disease. Balint 
et al. (1963) have shown that there is probably a decreased amount 
of cholestrol, cephalins (PS & PE), and sphingomyelin in an adult 
patient with Gaucher disease as compared to normal adult erythrocyte 
lipids. 
Treatment 
Recently, a bone-marrow transplant was performed in a patient 
with type 3 Gaucher disease with no change in clinical status post-
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transplantation. The plasma glucocerebroside concentration, however, 
returned to normal implying that the enzymatic abnormality in hemato-
paietic cells in Gaucher disease may be correctable by bone-marrow 
transplantation (Rappeport & Ginns, 1984). 
Several trials of enzyme replacement via placental S-gluco-
sidase infusion have also been tried but to no avail since the enzyme 
was not taken up by the appropriate macrophage. Thus, the only treat-
ment available for Gaucher disease is in the form of supportive treat-
ment (Brady & Barranger, 1983). 
Membrane Fluidity 
Concept of Membrane Fluidity 
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Fluidity specifically refers to the physical state or dynamics 
of the fatty acyl chains comprising the membrane bilayer (Chapman, 
1983; Stubbs & Smith, 1983). Phenomena relevant to fluidity encompass 
unsaturation and acyl chain length of fatty acids, lateral and rota-
tional mobility of phospholipids, changes in the frequency of trans-
gauche isomerization of C-C bonds of methylene groups in the phospho-
lipid acyl chains, changes in the swinging motion of the phospholipid 
fatty acyl chains, changes in phospholipid headgroup conformation, 
changes in interaction of cholesterol with membrane lipids, and changes 
in the intera~tion of proteins with lipids (Shinitzky & Barenholz, 
1978; Houslay & Stanley, 1982; Chapman, 1983; Stubbs & Smith, 1983). 
The extent of unsaturation and chain length of fatty acids 
is an important determinant of biomembrane fluidity. The exact cor-
relation with membrane fluidity to the unsaturation and fatty acyl 
chain length seems varied and complex depending on the number, posi-
tion, and type of the double bonds, the nature of membrane under in-
vestigation and the method used to probe the membrane physical state 
(Stubbs, 1983). Using model membranes it has been concluded that 
the effect of increasing the unsaturation results in only a slight 
increase in acyl chain mobility (Stubbs & Smith, 1984). A decrease 
in double bond index/saturated fatty acid ratio, defined as: 
(number unsaturated mol x no. double bonds) 
(number saturated mol) 
has been used as a chemical measure of membrane fluidity (Farias et 
al., 1975). This assumption is valid when other parameters such as 
cholesterol/phospholipid ratio remain constant and the fatty acid 
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double bonds of compared membranes have the same cis structure (Castuma 
& Brenner, 1983). Studies with biological membranes show that a sig-
nif cant change in level of unsaturation and chain length does not 
necessarily lead to changes in fluidity as measured with fluorescent 
or ESR probes (Gilmore et al., 1979a,b; Herring et al., 1980; Stubbs 
et al., 1980; Stubbs & Smith, 1984). 
Various head groups, lateral and rotational mobility, trans-
gauche isomerization, and fatty acyl chain swinging motions of phos-
pholipids are relevant to membrane fluidity. Similar to the data 
for unsaturation and fatty acyl chain length mentioned previously, 
the influence of the phospholipid head groups on the motion of the acyl 
chain (and thus fluidity) in cell membranes is complex and varied 
(Gilmore et al., 1976b; Stubbs, 1983). Although it is clear that 
the head group region has an influence on acyl chain motion, it is 
difficult to assess its importance in biological membranes due to 
the fact that the phospholipids in membranes have differing fatty 
acid composition (Stubbs, 1983). With respect to the lateral and 
rotational mobility, trans-gauche isomerization and fatty acyl chain 
swinging motions of phospholipids, it is known that they all can in-
fluence the membrane fluidity; however, the fluorescence method util-
ized in this dissertation cannot discern the effects of these param-
eters (Stubbs, 1983; Stubbs & Smith, 1984). 
Cholesterol is a principal modulator of membrane fluidity. 
This lipid has rigid, planar, wedge-shaped structure which orients 
perpendicular to the membrane bilayer, with the hydroxyl group in 
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the vicinity of the fatty acyl carbonyls, as shown in Figure 2 (Houslay 
& Stanley, 1982; Stubbs, 1983). Cholesterol has the ability to con-
dense phospholipid bilayers (Kitajima & Thompson, 1977). A variety 
of physical techniques have demonstrated that cholesterol has a small 
fluidizing effect below the phase transition temperature (gel phase) 
of phospholipids and a large rigidizing effect above this temperature 
(Oldfield & Chapman, 1972; Kawato et al., 1978; Chapman, 1983). 
Presence of large amounts of cholesterol prevents lipid chain crystal-
lization and removes phase transition characteristics (Chapman, 1983). 
In general, therefore, the effect of cholesterol in biological mem-
branes is to decrease fluidity (Kawato et al., 1978; Hildenbrand & 
Nicolau, 1979). The cholesterol/phospholipid ratio has been used to 
represent the amount of order (rigidity, inverse of fluidity) in mem-
branes (Shinitzky & Barenholz, 1978; Van Blitterswijk et al., 1981; 
Houslay & Stanley, 1982). 
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Fig. 2. Schematic representation of a cholesterol molecule 
with a phospholipid in a lipid bilayer. Adapted from Houslay and 
Stanley (1982). 
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Proteins also have translational and rotational movements in 
the membrane. This has been investigated on the bacterial protein 
rhodopsin; where it was shown by electron spin resonance that proteins 
have specific rotational diffusion rates (Barrion et al., 1977) and, 
by fluorescence photobleaching recovery, that proteins have a specific 
lateral diffusion rates as well. The estimation of the contribution 
of membrane proteins to membrane fluidity depends on the type of mem-
brane involved and the method used to determine membrane fluidity. 
In contrast to electron spin resonance and fluorescence photobleaching 
recovery, steady-state fluorescence anisotropy of proteins using the 
probe diphenylhexatriene gives virtually no contribution to fluidity 
in lymphoid, liver, hepatoma, and erythrocyte membranes (Van Blitter-
swijk et al., 1981). 
20 
Along with nature of fatty acyl composition, cholesterol, 
phospholipid structures, and proteins there are various physical ef-
fectors of lipid fluidity including pressure, pH, membrane potential, 
Ca2+ concentration and temperature (Shinitzky & Yuli, 1982). Of these, 
temperature plays an important role in membrane fluidity; and it can 
be generally stated that fluidity increases with increasing temperature 
and this corresponds to an overall increase in molecular motion 
throughout the membrane bilayer. 
With respect to the effect of temperature on membrane fluidity, 
one can observe various phases of lipids as the temperature is varied 
in biological membranes (phase transition). This phase transition 
occurs at characteristic temperatures for a particular phospholipid 
species. Phase transition detects lipid phase separations in the 
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biological membranes, where lipid phase separation can be defined as 
spontaneous coexistence of membrane domains with different composition 
(Grant, 1983). The two phases for phospholipids are: crystalline-
solid state where the acyl chains of phospholipid are fully extended 
parallel to the bilayer with their C-C bonds in the all-trans position, 
and liquid-crystalline (fluid) state in which there are rotational 
isomers about the C-C bonds of the fatty acyl chains (Houslay & 
Stanley, 1982). 
At the lipid phase transition temperature the bilayer changes 
from solid to the fluid state. The nature of the headgroup, the length 
of the fatty acyl chain, and the number, position and type of double 
bonds in the acyl chain of a phospholipid determine its phase transi-
tion temperature (Houslay & Stanley, 1982; Chapman, 1983). It should 
also be noted, however, that since cholesterol increases the rigidity 
of fluid-state lipid bilayers and increases the fluidity of solid-
state lipid bilayers, it may tend to cancel or dampen the lipid phase 
transition in biological membranes (Oldfield & Chapman, 1972; Houslay 
& Stanley, 1982; Chapman, 1983). As a theoretical consideration, 
the evidence for lateral phase separation comes from studies showing 
non-linear Arrhenius plots of the temperature dependence of fluores-
cence anisotropy (Shinitzky & Yuli, 1982; Stubbs, 1983). 
Techniques for Determining 
Membrane Fluidity 
NMR 
Nuclear magnetic resonance (NMR) studies of membrane structure 
employ the (2H) NMR method with high field superconducting magnets to 
investigate the organization of polar headgroups and backbone and 
hydrocarbon chain regions in phospholipids and glycolipids (Smith & 
Oldfield, 1984). With the deuterated species of interest incorporated 
into the membrane, motional characteristics of C-H bond can be deter-
mined by this technique. From this, it has been possible to obtain 
an order profile for phospholipid acyl chains (Seelig & Seelig, 1977). 
The drawback of performing NMR studies is the expensive apparatus 
required and the need to synthesize specially deuterated lipids in 
relatively large amounts. Also the calculations and assumptions in 
deriving the rate of motion are very complex and may be less reliable 
than those obtained in fluorescence studies (Stubbs, 1983). 
ESR 
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Electron spin resonance of a nitroxide probe in the membrane 
bilayer can give information on relaxation (mobility) of the probe, 
orientation of the probe with respect to its environment, concentration 
of the label in a given phase, order of the system, and the lateral 
diffusion of the probe in the plane of the bilayer (Jain & Wagner, 
1980). Much of the information on membrane structure has arisen from 
ESR studies. The theory behind ESR is similar to that of NMR and has 
been reviewed extensively elsewhere (Cantor & Schimmel, 1980). One 
of the major drawbacks for .this technique is similar to that of NMR 
in which the equipment is expensive. Also, one needs to synthesize 
spin-labeled probes,and the probe perturbs the system. 
Raman Spectroscopy 
Raman spectroscopy is a relatively new technique for deter-
mining acyl chain motions in membranes by looking at the vibrational 
states of C-C bonds. Even though it is a non-perturbing technique 
which has provided information on model lipid bilayers, interference 
from bonds in the phosphate and protein regions occurs with biological 
membranes (Stubbs, 1983). It is still in its infancy stages and much 
more experimentation is needed in order for this to be a major tool 
in membrane fluidity investigations of biological membranes. 
Fluorescence Spectroscopy 
Fluorescence spectroscopy is based on the phenomenon that 
when a fluorophore is excited by light, the fluorophore absorbs the 
energy and emits photons of lower energy. This phenomenon then can 
be adapted to give information on the orientation or range and rate 
of motion of the fluorophore and its adjacent environment. There 
are several fluorescence techniques which give information on lipid 
rotational motion including fluorescence photobleaching recovery and 
fluorescence anisotropy. 
In fluorescence photobleaching recovery, membrane lipids are 
labeled with a fluorescent compound and a small area of labeled cell 
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is exposed to a laser pulse. The time dependence of fluorescence 
recovery in the bleached area is followed over time and from it lateral 
diffusion constants can be obtained (Golan et al., 1983; Stubbs, 
1983). This has been used to determine lateral diffusion of proteins 
as well as lipids and the way lipid-protein interaction may occur 
(Golan et al., 1984; Spiegel et al., 1984). 
Fluorescence anisotropy techniques can include both time-
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resolved decay and steady-state anisotropy measurements. Time-resolved 
fluorescence anisotropy decay gives information on the range of acyl 
motion and the rate of motion. Investigators using the fluorescent 
probe DPH, a rod shaped molecule which aligns parallel to the acyl 
chains in the middle of the membrane bilayer, have assumed the range 
of acyl chain motion to be contained within a volume approximating 
to a cone which has an half angle (8c) (Kawato et al., 1977; Kinosita 
et al., 1977; Kawato et al., 1978)--also known as "wobbling-in-cone" 
model. From the half angle, one can determine the order parameter 
(S): 
S = [1/2 cos 8c (1 + cos 8c)J2. 
The rate of probe motion is described as the wobbling diffusion con-
stant CDw), which is obtained from the apparent rotational relaxation 
time (¢): Dw = o/¢, where a has been experimentally determined (Kawato 
et al., 1978; Stubbs et al., 1984). 
Steady-state fluorescence anisotropy gives information on 
rate of rotational diffusion of the probe as well as range of motion 
of the probe (Van Blitterswijk et al., 1981; Stubbs & Smith, 1984). 
Steady-state fluorescence measurements give information on the micro-
viscosity as well as the order parameter in relation to decay measure-
ments--to be discussed in the next section in considerable detail. 
Fluidity parameters of lipids in biomembranes are usually determined 
via this method and the information obtained is an overall average 
of all lipid domains present in cell membranes. Fluorescence ani-
sotropy measurements have several advantages over ESR and NMR in that 
it can be readily applied to complex systems such as biological mem-
25 
branes, the polarized signal is highly sensitive and reproducible, 
and the data obtained are promptly interpretable (Shinitzky & Baren-
holz, 1978). Whereas, fluorescence anisotropy decay measurements 
take longer and require complex apparatus and analysis (Stubbs, 1983). 
Steady-State Fluorescence Anisotropy 
Theory 
When a fluorophore is incorporated into biomembranes and it 
is excited by a continuous source of plane polarized light (along 
z-axis in figure 3), the steady state fluorescence anisotropy (rs) 
and polarization (p) can be determined by the emission intensities 
through an analyzer oriented parallel ( I 11 ) and perpendicular (IJ_) 
to the direction of polarization of the excitation light. Generally, 
the emission is detected at a right angle to the excitation, and the 
direction of polarization of I 11 is along z-axis and IJ_ is along y-axis 
in the figure. From this, the values for fluorescence polarization 
and anisotropy can be calculated as: 
p II I - IJ. (1) = 
+ IJ. Ill 
I11 - Il. 2P (2), rs = 
I11 + 2IJ. 3 - p 
where the range of P is -1/3<P<l/2 and rs is -1/5<rs<2/5. The total 
fluorescence intensity (F) can be calculated as: 
F = I1 I + 2Il. (3). 
From the steady-state fluorescence anisotropy determinations of the 
membrane in question, there are two ways to evaluate and interpret 
membrane fluidity. One interpretation is that the anisotropy reflects 
z 
µ 
Detector 
x 
Fig. 3. Schematic representation of various parameters 
utilized in fluorescence polarization. Adapted from Cantor and 
Schimmel (1980). 
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the rate of rotational diffusion of the probe, or microviscosity. Note 
that the average fluidity of the membranes can then be calculated as 
the reciprocal of the apparent microviscosity {n). The apparent micro-
viscosity of the membrane interior is estimated by comparing the flu-
orescence anisotropy in the system with that observed in a macroscopic-
isotropic system {reference mineral oil) and applying the classical 
hydrodynamic system of Perrin to yield the Perrin equation: 
n = c TT{:_o -1)-l (r ) rs 
s 
{ 4) • 
where C(r ) is a parameter which relates to the molecular shape and 
s 
the location of the transition dipoles of the fluorophore as expressed 
in the determined anisotropy {rs) values, T is the absolute tempera-
ture, T is the excited state lifetime of the probe, and r 0 is the 
limiting value of rs at infinite viscosity. The units for n is dyne-
s-cm-2 which is defined as 1 P {poise) {Shinitzky & Barenholz, 1978). 
The values for C(r )' r 0 and T can be determined 
s 
for the individual probe in question. However, the values for DPH, 
a widely used and efficient probe, have been determined to yield r 0 
= 0.362 and C TT remains relatively constant in liposomes and model (r) 
membranes yielding a value of 2.4 poise for temperatures between 0-40°C 
{Shinitzky & Barenholz, 1978). From this, an approximate value of n 
can be calculated for DPH in membranes to yield: 
0.362 - rs = 
2P (5). n = 0.46 - p 
It can be seen from this modified empirical Perrin equation that as 
the value of anisotropy increases, the apparent microviscosity in-
creases and, thus, the fluidity decreases. 
From the microviscosity, phase transitions and thus phase 
separation in lipids can be determined by the Arrhenius plot of log 
n versus 1/ T. If there are any phase separations of lipid domains, 
the Arrhenius plot will be non-linear; whereas, if there is a straight 
line in the Arrhenius plot, it implies that there are no phase transi-
tions of the lipid under investigation and thus the steady-state flu-
orescence polarization technique cannot detect phase separations of 
lipid domains (Shinitzky & Barenholz, 1978). 
One of the major assumptions in the Perrin type calculations 
for apparent microviscosity is that the probe is localized in an iso-
tropic medium; whereas, membranes have an anisotropic environment. 
Although the apparent microviscosity calculated may not be absolute, 
it is useful in comparing membrane fluidities. The second interpreta-
tion of the steady-state fluorescence anisotropy data comes from time-
resolved fluorescence polarization decay measurements. From this, 
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it was interpreted that it is mainly the degree to which the fluoro-
phore rotations are restricted by the molecular packing of the lipids 
(a static factor), rather than its rotational rate (a dynamic factor), 
which determines the steady-state fluorescence anisotropy in lipid 
membranes. Thus, rs can be resolved into a static part r
00 
(propor-
tional to the square of lipid order parameter), and a dynamic parameter 
rf (related to the rotational relaxation time of the fluorophore--which 
in turn is proportional to the microviscosity) (Van Blitterswijk et 
al., 1981; Pottel et al., 1983). As an equation, 
rs= rf + roo (6). 
Also, for the probe DPH, the limiting fluorescence anisotropy, r 00 , 
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is proportional to the square of the lipid order parameter, S 
O<S<l (7) 
where r 0 is the fluorescence anisotropy value in th~ absence of a 
rotational motion of the probe and is 0.362 for DPH in biological mem-
branes. 
From experimental data for the steady state fluorescence ani-
sotropy (rs) and the limiting fluorescence anisotropy (r00 ) of a variety 
of artificial and biological membranes, an empirical relationship can 
be arrived: 
(8) 
in the region 0.13 < rs <0.28--which is the value for most biological 
membranes. From equations 7 and 8, the order parameter can be calcu-
lated 
4 1/2 
Sopff = C -3 rs_ 0.28 ) ro ( 9) • 
As can be seen from equation (9), as the anisotropy increases, so 
does the order parameter. 
It is believed by Van Blitterswijk et al. (1981) that the 
structural order of membrane lipids is related to the degree of molec-
ular packing. Lipid fluidity may then be defined as the reciprocal 
of the lipid structural order parameter (Sopff) rather than apparent 
microviscosity. The physical state of the biological membrane can thus 
be suitably described by the order parameter (Pottel et al., 1983). 
In this theory, also, lateral phase separation can be determined by 
the non-linear Arrhenius plots of the steady-state fluorescence ani-
sotropy versus the temperature (Stubbs, 1983). 
Although the apparent microviscosity is not in an absolute 
scale and the lipid order parameter (Sopff) only takes into account 
the static component of rs, both of these parameters can be considered 
to define the inverse of lipid fluidity. It is not certain at this 
point which interpretation of steady-state fluorescence anisotropy 
data is appropriate; however, they both imply that an increase in 
steady-state anisotropy value of the membrane is due to a decrease 
in membrane fluidity (Castuma & Brenner, 1983). 
Fluidity Probes 
There are several probes utilized in studying membrane fluid-
ity. Of the many examples, fluorescent probes can be divided into 
two major classes. The first class includes fluorescent compounds 
which can incorporate spontaneously into a well defined lipid region 
of membranes--thus, directly reflecting the membrane fluidity from 
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its fluorescence anisotropy values. The other class includes flu-
orescent dyes which are covalently attached to fatty acids or phos-
pholipids (Shinitzky & Barenholz, 1978). Examples of the first class 
include l,6-diphenyl-1,3,5-hexatriene (DPH) and perylene; whereas, 
examples of the latter class include parinaric acid and its phospho-
lipid derivatives,l-acyl-2-N-4-nitrobenzeno-2-oxa-1,3-diazole-amino-
caproyl phospholipid (NBD-phospholipid), and DL-12-(9-anthroyl) stearic 
acid. In the context of membrane fluidity, the most efficient probes 
are perylene and DPH and thus shall be discussed in some detail. 
Perylene 
Perylene is a flat aromatic molecule with an approximate shape 
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of a disk with a diameter of 0.8 nm, as shown in Figure 4 (Zannoni 
et al., 1983). The absorption and emission spectrum of perylene over-
lap somewhat and exhibit a good mirror symmetry. It is a stable flu-
orophore with a considerably shorter fluorescence decay time of 'o = 
7.2ns; whereas •o for DPH = 11.4 ns. Also, the excited state lifetime 
of perylene is much more sensitive to temperature or fluidity changes 
--thus, this probe is used similar to DPH in high fluidity systems 
(Shinitzky & Barenholz, 1978). 
DPH 
DPH is one of the most useful and efficient probes for studying 
membrane fluidity. It is a rigid, rod shaped molecule, approximately 
1.3 nm long, with cylindrical symmetry, as shown in Fig. 5 (Zannoni 
et al., 1983). DPH absorbs light in near uv and emits with very high 
quantum yield in the blue region of visible spectrum. The absorption 
spectrum of DPH in various organic solvents is shown in Figure 6. 
It can be noted that the absorption spectrum changes as the polarity 
of the solvent changes. The absorption maximum occurs around 355 nm 
with an extinction coefficient of 80,000 M-lcm-1 (Shinitzky & Baren-
holz, 1978). In contrast to the absorption spectrum, the emission 
spectrum of DPH changes very little with a change in solvent. Particu-
larly, the emission maximum is relatively insensitive to changes in 
polarity, viscosity and temperature (Zannoni et al., 1983). The ab-
sorption and emission spectra do not show a good "mirror symmetry." 
This probe in membranes has a high and constant value of r 0 of 0.362 
and a fluorescence decay time of •o = 11.4 ns. 
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Fig. 4. (a) The molecular structure of perylene. (b) The 
disk-like shape assumed for perylene. Adapted from Zannoni et al. 
(1983). 
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Fig. 5. The molecular structure of DPH with the rod-like 
shape. Adapted from Zannoni et al. (1983). 
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Fig. 6. The absorption and fluorescence spectrum of DPH in 
various organic solvents: ethanol (~-); dioxane (---);hexane (···). 
Also shown is the polarization of fluorescence as a function of wave-
length determined in polypropylene glycol at T = -50°C. Adapted from 
Zannoni et al. (1983). 
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There are certain favorable properties of DPH which allow it 
to be an excellent membrane fluidity probe. It has no fluorescence 
signal when in an aqueous environment; however, when incorporated 
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into the lipid bilayer, it displays a sharp fluorescence signal 
(Shinitzky & Barenholz, 1974, 1978). Its high extinction coefficient 
and fluorescence quantum yield allow the detection of a fluorescence 
signal even at very low concentration (approximately lµM). The sepa-
rated absorption and emission reduce the possibility of energy transfer 
between DPH molecules and facilitate the elimination of excitation 
light scattering. The rod like shape aligns itself normally with 
the long axis parallel to the lipid chains (Lentz et al., 1976a,b). 
One of the more debated questions regarding the probe DPH is 
its location in the membrane bilayer. Owing to its property that 
DPH in bilayers is similar to that in apolar organic solvents, and 
it is relatively insoluble in water implies that DPH is located in 
the hydrocarbon region of the bilayer. The orientation of the long 
axis of DPH is believed to be parallel to that of the lipid chains 
(Lentz et al., 1976a,b; Thulburn, 1981; Zannoni et al., 1983). Once 
DPH has been incorporated into the bilayer, it partitions equally well 
into fluid or solid lipid domains (Lentz et al., 1976a,b). The derived 
fluidity represents the weight average of all lipid domains (Shinitzky 
& Barenholz, 1978). 
DPH in Biological Membranes 
DPH has been extensively used as a probe in model membranes 
such as liposomes and micelles as well as biological membranes. With 
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respect to the biological membranes, DPH has been used both in isolated 
cell membranes and in intact cells. When DPH is introduced into vari-
ous membrane lipids of intact cells, the dye is dissolved in the sur-
face membrane lipid·layer within minutes (Shinitzky & Barenholz, 
1978). The fluorescence of the labeled cells is initially confined 
to the plasma membrane; however, with time the probe molecules parti-
tion into the cell inner membranes until an equilibrium distribution 
is reached. Pagano et al. (1977) have shown using autoradiographic 
methods that DPH, when incubated with intact fibroblasts locates itself 
not only on the cell surface membrane but also in the cytoplasmic 
regions. It should be noted, however, in this method the labeled 
cells are treated with cross-linking agents and ethanol, and the ex-
posure time is days or weeks. The conditions are non-physiological 
and thus may increase the rate of partitioning of the probe. Also, 
Bouchy et al. (1981) have analyzed the evolution of DPH fluorescence 
polarization following incubation in living cells. They found a de-
crease of rs and r~ with time, a decrease not present in isolated 
plasma membranes. This is also questionable since Haggerty et al. 
(1977) found no difference between plasma membrane and cell micro-
viscosity using fibroblasts. However, it is important to note that 
the fluidity of the whole cell gives physiologically important informa-
tion which may be used in comparing disease states with normal con-
trols. One can also determine the lipid fluidity in plasma membranes 
of intact cells by selective quenching (Grunberger et al., 1982). 
As stated previously, the steady-state fluorescence anisotropy 
using DPH has been measured in diseased states and there are several 
r 
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lipid abnormalities which correlate with an altered anisotropy values. 
It is known that the cholesterol/phospholipid ratio is related to the 
inverse of fluidity. In red cells of patients with liver disease, 
the cholesterol/phospholipid (mol/mol) ratio is increased to 1.0-1.6 
from normal values of 0.9-1.0 with the concomitant decrease in membrane 
fluidity in the diseased state (Cooper et al., 1972, 1978; Owen et al., 
1982). As another example, the cholesterol/phospholipid ratio is 
decreased in mouse thymus derived ascitic leukemic (GRSL) cells as 
compared to normal thymocytes (GRSL = 0.22-0.30, normal thymocyte = 
0.37). This is correlated with the increased fluidity observed in 
the GRSL cells <nGRSL = 1.73P,n thymocyte = 3.24P) (Van Blitterswijk 
et al., 1977). Also, the cholesterol/phospholipid ratio is signif-
icantly elevated (0.52 + 0.045 versus 0.129 + 0.012) in cord mono-
nuclear leukocytes as compared to adult cells and this is again cor-
related with increased microviscosity values (polarization values of 
0.339 + 0.030 versus 0.186 + 0.019) (Neufeld & Carbo, 1984). 
Another factor important in fluorescence anisotropy values 
is the sphingomyelin to phosphatidylcholine ratio. There is an in-
crease in the phosphatidylcholine/sphingomyelin (mol/mol) ratio in 
sheep red blood cells treated with EGTA as compared to non-treated 
red blood cells (0.14 :t_0.01 versus 0.030 :t_0.005); this increase in 
phosphatidylcholine/sphingomyelin ratio is concomitant with an increase 
in lipid fluidity ((r 0 /rs - 1)-l values at 25°C of 2.22 + 0.004 versus 
2.58 + 0.004). In this study, however, there was no increase in the 
ratio of cholesterol/phospholipid noted (Borochov et al., 1977). 
Also, the microviscosity of erythrocyte membranes from patients with 
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abetalipoproteinemia was increased compared to normal erythrocytes 
(nacanthocyte = 4.01 - 4.14, nnormal = 3.2 + O.lP) which then is ex-
plained in terms of an excess amount of sphingomyelin in acanthocyte 
membranes with a concomitant increase in the sphingomyelin/phospha-
tidylcholine ratio (0.84 :t_ 0.08 in normals, 1.45-1.61 in acanthocytes) 
(Cooper et al.,1977). Van Blitterswijk et al. (1981) have also stated 
that sphingomyelin/total phospholipid ratio is an important determinant 
in fluidity of membranes. They show that for certain membranes, cho-
lesterol/phospholipid ratios remain constant but there is an altered 
structural order parameter; and this could be due to an altered 
sphingomyelin/phospholipid ratio. The authors stipulate that the 
sphingomyelin/phospholipid ratio is directly proportional to the order 
parameter (and thus inversely to fluidity). 
It is interesting to note that cholesterol/sphingomyelin ratio 
may also be important since it has been theoretically proposed that 
cholesterol tightly associates with sphingomyelin (Patton, 1970). 
The existence of a strong preferential interaction between cholesterol 
and sphingomyelin has been proven in artificial membranes (Barenholz 
& Thompson, 1980). At this moment, the exact ratio of cholesterol/ 
sphingomyelin has not been correlated with any fluidity change, but 
the literature does point to it (Barenholz et al., 1981; Barenholz & 
Thompson, 1980; Van Blitterswijk et al., 1981). 
When cholesterol/phospholipid ratio and sphingomyelin/ phos-
phatidylcholine ratio are constant but there is an altered membrane 
fluidity, the double bond index/saturated fatty acid ratio can be 
correlated with the changes in fluidity. A decrease in this ratio 
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leads one to conclude that there might be a decrease in lipid bilayer 
fluidity (Farias et al., 1975). As an example, this has been done 
with livermicrosomal membranes from guinea-pigs on a fat-free diet 
in which there was a decrease in membrane fluidity with no change in 
cholesterol/phospholipid ratio. However, there was a decrease in 
the double bond index/saturated fatty acid ratio corresponding to the 
decreased membrane fluidity. 
It is known that certain organisms can adapt to changes in 
their environmental temperature by altering their lipid composition 
and a constant lipid fluidity is maintained--termed homeoviscous adapt-
ation. Cultured cells have a limited ability to exhibit the property 
of homeoviscous adaptation. A transformed murine fibroblast cell 
line, LM cells, grown in a defined synthetic medium with supplements 
of choline or its analogues N,N'-dimethylethanolamine or N-monomethyl-
ethanolamine, was able to maintain plasma membrane fluidity constant 
by altering the degree of saturation of acyl chains in all classes 
of phospholipids. Only an ethanolamine supplement caused a decrease 
in the fluidity of the plasma membrane; again, alterations in the 
fatty acid composition of phospholipids was seen (Schroeder, 1978). 
This method of supplementation cannot be used to assess any changes 
in fluidity but it is a useful means of manipulating membrane lipid 
composition and testing for the sensitivity of membrane probes to 
changes in their lipid environment (Houslay & Stanley, 1982). 
Abnormalities in Cultured Human 
Skin Fibroblasts 
Owing to its many useful and well defined properties, DPH 
has been used to evaluate membrane fluidity, via fluorescence an-
isotropy, of a variety of cell membranes. In particular, it has been 
used on cultured human skin fibroblasts from subjects with various 
diseases with interesting results. This information is summarized in 
Table 2. 
As shown in Table 2, there is decreased polarization value 
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in fibroblasts obtained from homozygous familial hypercholesterolemia 
as compared to controls in both the intact cells and plasma membranes. 
It is interesting to note that there is no difference in the polari-
zation values of intact fibroblasts as compared with plasma membranes. 
Shaw et al. (1983) have shown that the difference or no difference 
observed between the total cell membrane fluidity and plasma membrane 
fluidity could be due to the way a plasma membrane is prepared. They 
seem to suggest that the method of membrane preparation is an essential 
step in determining membrane fluidity. Using a sucrose-step gradient, 
they have isolated plasma membranes from fibroblasts obtained from 
normal subjects as well as fibroblasts from subjects with Duchenne 
muscular dystrophy; and on these isolated membranes, membrane fluidity 
measurements using DPH revealed an increased fluidity of membranes as 
compared to matched controls. Fluidity in Huntington disease fibro-
blasts has also been evaluated and there is no difference observed 
between controls and diseased membranes--either in intact cells, plasma 
membranes, microsomes or mitochondrial membranes. Even though this 
technique of determining membrane fluidity has been used only in a 
few disease states using cultured human skin fibroblasts, it has a 
TABLE 2.--Fluorescence Polarization (25°C) of Cultured Human Skin Fibroblasts from Various Diseases 
Description of Various 
Cell Lines 
1. a. Normal Control 
Caucasian (n=2) 
Negro (n=4) 
b. Homozygous familial 
hypercholesterolemia (n=4) 
2. a. Control, 22°c (n=9) 
b. Duchenne dystrophy 
fibroblasts, 22°c (n=9) 
3.*** a. Control (n=lO) 
b. Huntington fibroblasts 
(n=ll) 
4.*** a. Control (n=9,8,8) 
b. Huntington fibroblasts 
(n=9,8,8) 
Fluorescence Polarization 
Intact Cells 
0.242 + 0.003 
0.238 + 0.005 
0.206 + 0.006 
0.2639 + 0.0085 
0.2625 + 0.0179 
Plasma 
Membranes 
0.242 + 0.013 
0.259 + O.Oll 
0.208 + O.Oll 
0.306 + 0.016 
0.289 + 0.008 
0.299 + 0.010 
0.301 + 0.006 
Values represent mean + standard deviation. 
*microsomes; **mitochondria; ***mean + standard error of mean. 
Other 
Organelles 
0.308 + 0.010* 
0.266 + O.Oll** 
0.313 + 0.007* 
0.278 + 0.012** 
Ref. 
Haggerty et al. 
(1978) 
Shaw et al. 
(1983) 
Beverstock & 
Pearson 0981) 
Schroeder 
(1984) 
very useful potential in investigating inherited metabolic disorders 
--especially Gaucher disease. 
Lipid Composition of Cultured Human 
Skin Fibroblasts 
It is important to know the composition of lipids in fibro-
blasts in order to correlate this with the membrane fluidity measure-
ments. The amount of neutral lipids have been determined in normal 
human cultured skin fibroblasts and the major constituents seem to 
be cholesterol, cholesterol esters, and triglycerides. Some of these 
values are summarized in Table 3 (Chatterjee et al., 1976). 
Along with neutral lipids, one of the major lipid classes 
found in fibroblasts are the glycerophospholipids. In normal human 
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fibroblasts, there seem to be several important phospholipids including 
sphingomyelin, phosphatidylcholine, phosphatidylinositol, phosphatidyl-
serine, phosphatidylethanolamine, and some disphosphatidylglycerol 
and lysophosphatidylcholine (Chatterjee et al., 1976; Malkiewicz-
Wasowicz et al., 1977; Schroeder et al., 1984). The results of a 
typical phospholipid analysis in cultured fibroblasts is presented 
in Table 4 (Schroeder et al., 1984). 
Along with neutral lipids and phospholipids, fibroblasts also 
contain glycosphingolipids. Glycosphingolipids make up approximately 
3 percent of total membrane lipids (Dawson et al., 1972). Glyco-
sphingolipids can be divided up into neutral glycosphingolipids and 
acidic glycosphingolipids (gangliosides). Neutral glycosphingolipids 
in human fibroblasts consist of glucosylceramide (GlcCer), lactosyl-
ceramide (LacCer), globotriaosylceramide or trihexosylceramide 
TABLE 3.--Neutral Lipid Composition of Cultured Human 
Skin Fibroblasts 
Neutral Lipid µg lipid/mg of Protein 
Cholesterol 30 
Cholesterol Ester 18 
Triglyceride 34 
Data adapted from Chatterjee et al. (1976) 
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TABLE 4.--Phospholipid Composition of Cultured Human 
Skin Fibroblasts 
Phospholipid Composition (mole %) 
Phosphatidylcholine 50 + 5 
Phosphatidylethanolamine 19 + 3 
Phosphatidylinositol + 10 + 1 
Phosphatidylserine 
Sphingomyelin + 10 + 1 
Lysophosphatidylcholine 
Cardiolipin 6 + 1 
Data adapted from Schroeder et al. (1984). Number of 
samples was 4, values represent the mean :t..SEM. 
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TABLE 5.--Glycosphingolipid and Ceramide Composition of 
Cultured Human Skin Fibroblasts 
Glycosphingolipid 
Neutral 
Glycosphingolipid 
GlcCer 
LacCer 
GbOse3Cer 
GbOse4Cer 
Gangliosides 
GM3 
GHz 
GM1 
GD3 
GD1a 
Cerami de 
nanomol/mg of protein 
1.11 + 0.48 
0.41 + 0.17 
2.50 ±. 0.56 
1. 40 + o. 29 
3.13 + 0.32 
1.10 + 0.16 
0.26 + 0.03 
o. 71 + 0.24 
0.47 + 0.18 
5* 
Ref. 
Saito & 
Rosenberg 
(1984a) 
Chen et al. 
( 1981) 
*Concentration of ceramide expressed as µg/mg of protein. 
Values represent the mean ±_SD. 
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(GbOse3Cer) and globotetraosylceramide or tetrahexosylceramide 
(GbOse4Cer). Gangliosides in fibroblasts consist of sialosyl lactosyl 
ceramide (GM3), sialosyl gangliotriaosyl ceramide (GHz), sialosyl 
gangliotetraosyl ceramide (GM1), disialosyl lactosyl ceramide (GD3), 
and disialosyl gangliotetraosyl ceramide (GD1a> (Saito & Rosenberg, 
1984a). The actual amount is represented in Table 5. Ceramide also 
is a constituent of cultured human fibroblasts and it has been deter-
mined that its concentration is approximately Sµg ceramide/mg of pro-
tein (Chen et al., 1981). 
The lipid composition of cultured human fibroblasts may be 
altered by a disease process (due to an enzymopathy), such as Gaucher 
disease, or it may be altered by culturing the cells in the presence 
of chemical modulators. Monensin, a carboxylic monovalent cationo-
phore, is such a chemical which can modify membrane lipid structure. 
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It has been shown that monensin decreases activity of lysosomal enzymes 
by increasing the pH (Tartakoff, 1983) and may influence glycosphingo-
lipid biosynthesis in the Golgi apparatus (Saito et al., 1984). Using 
monensin, Saito et al. (1984) have shown that there is increased ac-
cumulation of the neutral glycosphingolipids GlcCer and LacCer in 
normal cultured human skin fibroblasts; and this accumulation is in-
creased in Gaucher diseased fibroblasts which then may be explained 
in terms of cation regulation. At this time, however, the effects 
of monensin on neutral lipids, phospholipids, and ceramide is not 
known. 
CHAPTER III 
MATERIALS AND METHODS 
Cell Culture 
Normal cultured human skin fibroblasts (Human Genetic Mutant 
Cell Repository GM 3440 [adult], GM 302A [infant]), type 1 Gaucher 
disease fibroblasts (GM 4394 [infant non-neuronopathic]), and type 2 
Gaucher disease fibroblasts (GM 877 [infant neuronopathic]) were ob-
tained from the Institute for Medical Research (Camden, N.J.). Other 
fibroblasts were obtained from Dr. David Wenger, University of Colorado 
Medical Center, Dr. A Beaudet, Baylor College of Medicine and Dr. 
A. Milunsky, E. K. Shriver Center (Waltham, Mass.)--type 1 Gaucher 
fibroblasts (AdG 1470, AdG 119a [adult non-neuronopathic]), type 2 
Gaucher fibroblasts (InG 1247 [infant neuronopathic]), and type 3 
Gaucher fibroblasts (JuvG [juvenile neuronopathic]). One normal adult 
fibroblast cell line was established from biopsy in our laboratory 
(NmlF) (Barton & Rosenberg, 1974; Mueller & Rosenberg, 1977; Saito 
et al., 1984}. 
All cell culture was performed according to well established 
methods using 10 ml of growth medium containing 88% Dulbecco's modified 
Eagle's medium (GIBCO}, 10% heat inactivated fetal calf serum (GIBCO, 
heated at 56°C for 30 min}, and 2% penicillin-streptomycin (5000 
I.U. and 5 mg/ml, respectively, Flow Laboratories} in 75-cm2 plastic 
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tissue culture flasks (Falcon) at 37°C in a 5% C02 atmosphere in air. 
Change of media was performed every 5-6 days until the cells were 
confluent. Approximate time for confluency is 10-14 days after seeding 
of fibroblasts. Unless otherwise noted, fibroblasts were between 
the fifth and nineteenth passage in this study. Total cell protein 
was determined by the method of Hartree (1972). 
Fluorescence Labeling of Cells 
The fluorescent hydrocarbon l,6-diphenyl-1,3,5-hexatriene (DPH, 
Aldrich) was used as a probe for monitoring the degree of fluidity 
of normal and diseased fibroblasts. Labeling of fibroblast membranes 
was done according to the modified procedures of (Shinitzky & Baren-
holz, 1974; Shinitzky & Inbar, 1974; Fuchs et al., 1975; Haggerty et 
al., 1978; Van Hoeven et al., 1979) where 2mM DPH in tetrahydrofuran 
was diluted 100-fold with vigorously stirred calcium and magnesium 
free phosphate buffered saline (PBS, pH 7.2) and was further stirred 
for 30 minutes under a nitrogen stream to evaporate the tetrahydro-
furan. Confluent fibroblasts, in 75 cm2 flasks, were then incubated 
with 10 ml of 20µM DPH for 1 hour; whereas, the controls were incubated 
with 10 ml of PBS for the same period of time at 37°C. After incuba-
tion, the cells were detached from the flask substratum, via trypsin 
(type III from bovine pancreas, Sigma) treatment (0.05% in PBS for 5 
min), and the trypsin activity was neutralized by the growth media. 
The cells were recovered by centrifugation (500 xg, 5 min) and sus-
pended in 2 ml of PBS and approximately 50 µl of it was taken to be 
counted in a hemocytometer (ultra plane Spotlite counting chamber, 
S/P). The cells were again centrifuged and resuspended in PBS, using 
the appropriate volumes to get the same cell numbers for labeled and 
unlabeled cells (: 1-5 x 106 cells/ml). These were then immediately 
used for fluorescence measurements. 
For some of these cells, trypan blue exclusion test was also 
performed to check the viability of the fibroblasts. After the label-
ing of cells and collecting the suspension, O.lml of 0.01% trypan 
blue in PBS was added to the 1 ml suspension of cells and incubated 
for 1-5 min and the cells were counted with a hemocytometer. The 
percentage of viable cells is calculated as: 
% viable cells=lOO[l- no. cells with trypan blue uptake] total no. cells counted 
Fluorescence Anisotropy Measurements 
Fluorescence anisotropy and intensity were measured with an 
MPF-44B Perkin-Elmer spectrofluorophotometer equipped with Polacoat 
polaroid polarizers and a thermostatically controlled cuvette holder 
attached to a Fisher Model 90 Refrigerated bath. Temperature was 
maintained by circulating water-methanol (1:1) through the cuvette 
chamber. The excitation wavelength used was 360 nm and emission wave-
length of 426 nm with slits 5 nm each along with a filter cutoff of 
390 nm. Fluorescence polarization (P) and anisotropy Crs)is obtained 
from fluorescence measurements via the equations: 
I 
- I h(Ih /Ih h) 
p = v,v v, ,v , I + I h(Ih /Ih h) v,v v, ,v , 
I 
-
1v
2
h( 1h
2
v11h 2h) 2P r = V 2V = s I + 21 h(Ih /Ih h) 3-P v,v v, ,v , 
where Iv,v is the corrected fluorescence intensity with the polarizers 
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parallel (excitation and emission polarizers set both at 0°) and Iv h 
' 
is the corrected fluorescence intensity with the polarizers horizontal 
(excitation polarizer set at o0 and emission polarizer at 90°). The 
factor in parenthesis, Ih,v/Ih,h is the transmission efficiency cor-
rection factor of the emission monochromator both parallel and per-
pendicular to the grooves of the grating. The corrected fluorescence 
intensity was determined by subtracting the intensity of polarized 
light measured with unlabeled control cells from the intensity observed 
with the labeled cells. For each of the intensity measurements a 20 
second integration is taken. For each experimental anisotropy, three 
independent readings were performed and averaged. 
For the different cell lines, anisotropy measurements were 
performed at 2s 0 c. In performing the temperature scan studies, the 
initial temperature was 4°C with an incremental increase of 4°C until 
40°C was reached. The temperature was monitored inside the cuvette 
with an YSI thermistor probe. 
From the fluorescence anisotropy (rs) measurements the apparent 
microviscosity (n) with units of Poise was calculated from the ex-
press ion 
-n = 
2.4 rs 
o.362 - rs 
as shown by Shinitzky and Barenholz (1978) and discussed in Review 
of the Related Literature. The order parameter values were calculated 
according to the procedure of Van Blitterswijk et al. (1981): 
S - ( 4 rs 0 28) 112 
- 3Q.362-. • 
For the temperature scans, Arrhenius plots of log rs versus l/tem-
perature (°K) were performed and analyzed for non-linear break points. 
Monensin Treatment and (3H) Acetate 
Labeling of Fibroblasts 
Confluent fibroblasts (GM 3440, normal adult) were incubated 
with 1 µM monensin (in ethanol, Calbiochem) in 10 ml culture medium 
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for 18 hrs. Equal volumes of ethanol were added to cells not incubated 
with monensin according to Saito et al. (1984). Along with this, 
all the cells were incubated with (3H) sodium acetate (New England 
Nuclear, specific activity of 685 mCi/mM). 50.0 µCi was used in 10 
ml growth medium. 
The amount of lipid was quantitated as described below by 
high performance silica gel G thin-layer chromatography (HPTLC). 
Radioactivity was determined by scraping each band of interest, trans-
ferring the samples into scintillation vials adding 5ml of Aquasol 
(New England Nuclear) and counting in a Beckman LS 1800 Scintillation 
Counter. External standards were established in the scintillation 
counter memory to determine the amount of quenching and counting ef-
ficiency; thus, from the actual counts per minute (cpm) the disintegra-
tion per minute (dpm) are reported. 
Lipid Isolation and Quantitation 
Confluent cells in 75 cm2 culture flasks were washed with 5 
ml cold PBS (4oc, pH 7.2, calcium and magnesium free) three times 
and harvested with a home-made rubber policeman. Total lipids were 
then extracted from the cells three times with 2 ml each of chloro-
form-methanol (2:1, v/v). The samples were then dried under nitrogen 
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(99.99% pure) and redissolved in chloroform and applied to a Unisil 
Column (activated silicic acid, 100-200 mesh, Clarkson Chemical Co., 
Pa.). Unisil column was prepared according to Saito & Rosenberg (1982) 
using glass wool in a 5-3/4" length pasteur pipet with silicic acid 
added up to 2 cm and pre-washed with chloroform-methanol (2:1, v/v). 
Neutral lipids were eluted first from the column with chloroform (3 
times with 2 ml) and then phospholipids with methanol (3 times with 
2 ml) after redissolving the sample in methanol and reapplying to 
the column. These lipids were then dried under nitrogen (99.99% pure) 
and are ready to be quantitated. 
The isolated neutral lipids were spotted on a 10 x 20 cm HPTLC 
(E. Merck, Darmstadt, Germany) plate along with 5 µl, 10 µl, 15 µl, 
and 20 µl of a standard neutral lipid mixture (consisting of 0.4 
µg/µ1 cholesterol, 0.06 µg/µl oleic acid, 1 µg/µ1 triglyceride and 
0.8 µg/µl cholesterol ester dissolved in dioxane and all chemicals 
obtained from Sigma). The plate was then developed in diethyl ether-
hexane-acetic acid (35:65:2, v/v) until the solvent front ascends to 
about 4-5 cm above the bottom edge of the plate. Following develop-
ment, excess solvent was evaporated in a fume hood for 15 minutes 
and then in a vacuum desiccator for 15 minutes. Then it was rechro-
matographed using diethyl ether-hexane-acetic acid (2:98:1, v/v) until 
the solvent front ascends to 1 cm of the top of the HPTLC plate. 
After drying the plate·several minutes in air, the lipids 
were charred for densitometry with 3% cupric acetate (w/v) in 8% phos-
phoric acid (v/v) solution and heated at 180°C for 15 minutes (Fewster 
et al., 1969) and scanned according to Macala et al. (1983) at 350 
nm (slit = 0.2 nm, width = 3 nm) in a Kratos model SD 3000 spectro-
densitometer (Kratos, Shoeffel Instrument Corp., N.J.) attached with 
a Hewlett-Packard 3390A integrator (Hewlett-Packard Co., Pa.). The 
scan was done in the "fast" mode on the densitometer along with the 
settings on the integrator as follows: attenuation = 6, chart speed 
= 6 cm/min, peak width = 0.04 min, threshold = 5, and area rejection 
= O. The lipids were then quantitated from comparison with the 
standard. Standard linear plots were determined for cholesterol, 
free fatty acid, triglycerides, and cholesterol ester separately as 
amount of lipid versus area under the curve and from it, the amount 
of sample lipid was determined. 
One-fourth the amount of isolated phospholipids were also 
spotted on a 10 x 20 cm HPTLC plate along with 5 µl, 10 µl, 15 µl, 
and 20 µl of a standard phospholipid mixture (consisting of 2 µg/µl 
sphingomyelin, 3 µg/µl phosphatidylcholine, 0.1 µg/µ1 phosphatidyl 
serine, 0.05 µg/µl phosphatidylinositol, and 0.5 µg/µl phosphatidyl 
ethanolamine dissolved in dioxane and all chemicals obtained from 
Sigma). The plate was then developed in chloroform-methanol-water 
(60:35:4, v/v) until the solvent front reached to 1 cm from the top 
of the plate. After drying the plate for several minutes in air, 
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the phospholipids were visualized and quantitated similarly as for 
neutral lipids (Macala et al., 1983; Schmitz et al., 1983, 1984; Gopelt 
& Resch, 1984). The scan on the densitometer was in the "slow" mode 
with the settings on the H-P 3390A integrator as follows: attenuation 
= 6, chart speed = 2 cm/min, peak width = 0.04 min, threshold = 5, 
and area rejection = O. 
Initially, to verify that the methanol elution from Unisil 
column did indeed give the phospholipids, phospholipids were plated 
and then sprayed with the Dittmer-Lester reagent (Dittmer & Lester, 
1964) specific for phospholipid, which gave a positive blue spot for 
the fibroblast phospholipids. They were also visualized with iodine 
stain to make sure no other lipids were present. Each phospholipid 
was then identified by comparing it with a standard spotted alongside 
it and noting the distance migrated. Each neutral lipid was also 
identified by comparing it with a standard. 
The yield of the phospholipid and neutral lipid was checked 
by densitometry. For example, the amount of neutral lipid isolated 
by chloroform elution from Unisil column was compared against neutral 
lipid content in total lipids and the result was approximately 95-99% 
of the neutral lipids were recovered, as judged via densitometry. 
This was also true for the phospholipids. 
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Ceramide was also quantitated in cultured human skin f ibro-
blasts. The total lipids were isolated as stated previously and dried 
under nitrogen. The lipids were then applied to a Unisil column by 
dissolving in chloroform-methanol (9:1, v/v) and eluted three times 
with 2 ml of this chloroform-methanol (9:1, v/v) mixture. This ceramide 
containing fraction was then dried under nitrogen and then applied 
to a HPTLC plate along with 5 ]J]., 10 ]J]., 15 ]J]., and 20 Ul of standard 
ceramide (0.05 ig/]J]. in C-M 2:1) obtained from Sigma (from brain 
sphingomyelin) and developed in chloroform-methanol-water (60:25:8, 
v/v) until the solvent front reached to approximately 3-3.5 cm from 
the bottom edge of the plate according to Selvam and Radin (1981). 
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Following development, excess solvent was evaporated in a fume hood 
for 15 minutes and then in a vacuum desiccator for 15 minutes. Then, 
it was rechromatographed using chloroform-methanol-acetic acid 
(90:2:8, v/v) until the solvent front ascends to 1 cm of the top of 
the HPTLC plate. The percentage recovery of ceramide was estimated 
to be approximately 90-95%, as judged by HPTLC plating and densitometry 
of the fraction containing chloroform-methanol (9:1) eluant versus 
total lipid fraction. The visualization and quantification of the 
ceramide was done exactly as that described for neutral lipids and 
phospholipids. This plate was then scanned with the densitometer in 
the "fast" mode with the settings on the H-P 3390A integrator as fol-
lows: attenuation = 6, chart speed = 7 cm/min, peak width = 0.04 
min, threshold = 5, area rejection = O. 
Fatty Acid Analysis of Phospholipids 
and Cholesterol Ester 
The phospholipids were isolated as described in the previous 
section. They were then plated onto a 10 x 20 cm plate (prewashed 
in the developing solvent system of chloroform-methanol-water [60:35:4, 
v/v]) and developed as before. Afterwards, the plate was air dried 
for a few minutes and visualized with iodine. Appropriate phospho-
lipids were marked along with blank regions and the iodine was evap-
orated under nitrogen. It was determined using standard phosphatidyl-
choline that the best way to keep unsaturated fatty acids from being 
degraded is to evaporate the iodine immediately with nitrogen, and, 
not in a vacuum desiccator. The marked spots were then scraped and 
dissolved in methanol and sonicated for 30 seconds. The individual 
lipids were then applied to a pasteur pipet, containing glass wool, 
and collected in 13 x 100 mm test tubes. The tubes were centrifuged 
to pellet any silica gel that may have been carried through with the 
methanol. The supernatant containing the phospholipid of interest 
was then placed into teflon capped 1/2 dram vials (Supelco, Inc., 
Bellefonte, Pa.) and then dried under nitrogen. The fatty acids were 
derivatized to their methyl esters by using either MeOH-HCl (0.5 N, 
Supelco) according to Zanetta et al. (1972) or BF3-MeOH (14% w/v, 
Supelco) according to Morrison and Smith (1964). 
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With respect to the MeOH-HCl (0.5 N) as the derivatizing agent, 
0.5 ml was added to the teflon capped vials and the vials were flooded 
with nitrogen for a few seconds, to replace the air, and the vials 
were then tightly capped. The vials were placed in a Multi-Blok Heater 
(Lab-Line Instruments, Inc., Melrose Park, IL) at 100°C for 20 hrs. 
After the said period of heating, the vials were cooled to room temper-
ature and the fatty acyl methyl esters were extracted twice with 0.5 
ml of hexane. The hexane was dried and a final volume of 50 µl hexane 
was added, and, 5 µl of this was subjected to gas chromatography. 
Similar to MeOH-HCl, 0.5 ml of BF3-MeOH was added to the teflon 
capped vials and the vials were placed under nitrogen for a few 
seconds. For all phospholipids, except sphingomyelin, the samples 
were heated at 100°C for 15 minutes. Sphingomyelin containing samples 
were heated at 100°C for 75 min. After cooling to room temperature, 
the fatty acid methyl esters were extracted twice with 0.5 ml hexane 
and dried under nitrogen. Afterwards, 50 µl of hexane was added, and, 
5 µl of this injected into the gas chromatograph. 
The fatty acids of cholesterol esters were examined similar 
to that of phospholipids. Neutral lipids from fibroblasts were ex-
traced as described in the previous section. These were then spotted 
on an HPTLC plate (prewashed in the solvent system of ether-hexane-
acetic acid [2:98:1]) and developed as described previously. After-
wards, the plate was air dried for a few minutes and visualized with 
iodine. The cholesterol ester bands were marked, along with the ap-
propriate blank, and the iodine was evaporated under nitrogen. The 
marked spots were then scraped and dissolved in chloroform and soni-
cated for 30 seconds. These then were applied to a pasteur pipet 
containing glass wool and collected in 13 x 100 mm tubes. The tubes 
were centrifuged (500 xg, 5 min) to pellet any silica gel that may 
have been present after passing through with chloroform. The super-
natant containing cholesterol ester was placed in a 1/2 dram teflon 
capped vial and dried under nitrogen. Then the fatty acids from cho-
lesterol esters were derivatized with BF3-MeOH (14% w/v, 0.5 ml/vial) 
at l00°C for 75 min. After cooling, the fatty acid methyl esters 
were extracted twice with 0.5 ml hexane and dried under nitrogen. A 
final volume of 50 µl was added to the dried lipids, and, 5 µl of 
this was injected into the gas chromatograph. 
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The fatty acid methyl esters were analyzed using a Perkin-Elmer 
990 Gas Chromatograph equipped with a flame ionization detector. The 
prepacked column was obtained from Supelco, Inc. containing 5% Ov-210 
on Supelcoport. The conditions used for gas-liquid chromatography 
are summarized in Table 6. 
The peaks obtained were identified using authentic standards 
TABLE 6.--Conditions for Gas Liquid Chromatography 
Using a Perkin-Elmer Model 990 G-C 
Condition 
Column Temperature: 
Initial 
Final 
Temperature Program Rate 
Manifold Temperature 
Injector Temperature 
Gas Flow Rates (All gases of Zero Grade) 
Hydrogen 
Air 
Nitrogen 
Sample volume injected 
Attenuation 
Cool Rate 
Hewlett Packard 3390A Integrator: 
Attenuation 
Chart Speed 
Peak Width 
Threshold 
Area Rejection 
Value 
90°c 
200°c 
4°C/min 
200°c 
240°c 
30 ml/min 
300 ml/min 
7.5 ml/min 
5 µl 
8 
fast 
2 
0.3 cm/min 
0.04 min 
1 
0 
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obtained from Sigma or Supelco. The weight percentage of each fatty 
acid was determined with respect to an external standard obtained 
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from Supelco (Supelco Standard F containing 12% C14:0, 4% C16:0, 7% 
Cl8:0, 14% C20:0, 25% C22:0, and 47% C24:0). Cholesterol ester fatty 
acids were analyzed with the G-C attached to a Hewlett-Packard inte-
grator, which predetermined the areas; whereas, phospholipid fatty 
acids were analyzed with a Fisher Recordall Series 5000 Chart recorder 
(0.01 volts, 1 cm/min chart speed) from which the area of each indi-
vidual peak was obtained by taking the product of height x base at half 
height. 
Hydrogenation 
For an unidentifiable peak in the fatty acids of cholesterol 
esters, the fatty acid methyl esters were subjected to platinum reduc-
tion using Adam's catalyst (Pt20) according to the method of Christie 
(1982). All of fatty acid methyl esters in hexane, as obtained above, 
were taken and dried under nitrogen. To this sample, 150 µl of meth-
anol (anhydrous) was added along with 1 mg of Adams' catalyst in a 
sealed pasteur pipet. The sample was then placed in a hydrogenation 
bottle and connected to a two-way tap reservoir of hydrogen. The sample 
was alternatively evacuated and flushed with hydrogen three or four 
times to remove any air, and then was vigorously shaken for two hours 
at a hydrogen pressure of 21 psi. After this time, the catalyst turned 
black; and the methanol containing reduced fatty acid methyl esters 
was transferred to another sealed pasteur pipet and an additional 
100 µ1 of methanol was added. From this, the fatty acid methyl esters 
were extracted twice with 400 µl hexane and placed into teflon capped 
vials. This was then dried under nitrogen and a final volume of 50 
µ1 hexane was added, of which, 5 µ1 was injected into the gas chrom-
atograph for identification. 
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CHAPTER IV 
RESULTS 
Fluorescence of DPH Incorporation into Cells 
A time course study was performed on normal and Gaucher dis-
eased fibroblasts at 25°C and it was noted that the steady-state flu-
orescence anisotropy value was constant up to the times investigated 
(Fig. 7). The fluorescence intensity was linear up to one hour for 
both normal and diseased cells (Fig. 8). The viability of the cells 
was also checked, using the trypan blue exclusion test, and almost 
95-99 percent of all the cells were viable up to 1 hr. In order to 
check that the DPH probe was incorporated into the fibroblasts, an 
emission spectrum of the labeled and unlabeled cells (excitation wave-
length = 360 nm) was performed for the different cell lines and the 
spectra showed the incorporation of probe into the cell membranes 
with a relative emission maximum at 426 nm (Figs. 9-15) for the normal 
and Gaucher diseased cell lines. Also, excitation spectra for one 
of the cell lines, GM 302A, is shown in Fig. lO(emission wavelength 
= 426 nm). Culture media's intrinsic autofluorescence was also checked 
and it was noted there was some probe incorporated into the media 
but not to a significant degree that would interfere with the subse-
quent anisotropy measurements. It can be noted that the labeled cells 
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Fig. 7. Time course study of fluorescence anisotropy of 
Normal, NmlF (e),and Gaucher, InG 1247 (O),fibroblasts. 
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versus time of incubation with DPH for normal, NmlF (e),and Gaucher, 
InG 1247 (O), fibroblasts. 
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Fig. 9. Emission spectra of DPH in normal infant fibroblasts 
(GM 302A). Curve (a) depicts fibroblasts labeled with DPH and curve (c) 
non-labeled cells at the same sensitivity of the fluorometer. Curve (b) 
is the same as for (c) except at a higher gain (30x). Excitation 
wavelength was 360 nm. 
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Fig. 10. Excitation spectra of DPH in normal infant fibro-
blasts (GH 302A). Emission wavelength was 426 nm. 
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Fig. 11. Emission spectra of DPH in type 1 infant Gaucher 
fibroblasts (GM 4394). Curve (a) depicts fibroblasts labeled with 
DPH and curve (c) non-labeled cells at the same sensitivity of the 
fluorometer. Curve (b) is the same as for (c) except at a higher 
gain. Excitation wavelength was 360 nm. 
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Fig. 12. Emission spectra of DPH in type 2 infant Gaucher 
fibroblasts (InG 1247). Curve (a) depicts fibroblasts labeled with 
DPH and curve (c) non-labeled cells at the same sensitivity of the 
fluorometer. Curve (b) is the same as for (c) except at a higher 
gain. Excitation wavelength was 360 nm. 
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Fig. 13. Emission spectra of DPH in type 3 juvenile Gaucher 
fibroblasts (JuvG). Curve (a) depicts fibroblasts labeled with DPH 
and curve (c) non-labeled cells at the same sensitivity of the 
fluorometer. Curve (b) is the same as for (c) except at a higher 
gain. Excitation wavelength was 360 nm. 
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Fig. 14. Emission spectra of DPH in normal adult fibroblasts 
(GM 3440). Curve (a) depicts fibroblasts labeled with DPH and curve 
(c) non-labeled cells at the same sensitivity of the fluororneter. 
Curve (b) is the same as for (c) except at a higher gain. Excitation 
wavelength was 360 nm. 
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Fig. 15. Emission spectra of DPH in type 1 adult Gaucher fibro-
blasts (AdG 1470). Curve (a) depicts fibroblasts labeled with DPH and 
curve (c) non-labeled cells at the same sensitivity of the fluorometer. 
Curve (b) is the same as for (c) except at a higher gain. Excitation 
wavelength was 360 nm. 
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have greater than 20-30 times the intensity as compared to non-labeled 
cells. 
Fluorescence Anisotropy of Normal and Diseased Cells 
Table 7 shows the steady-state polarization and anisotropy, 
measurements for the various cell lines at 2s 0 c. This ~able also 
has calculated average values for the apparent membrane microviscosity 
(n), limiting fluorescence anisotropy (r00 ), and the lipid order param-
eter (S) from the steady-state fluorescence anisotropy values as shown 
in Materials and Methods, and Review of the Related Literature. It 
can be seen that as compared to normal infant fibroblasts, type 2 
and type 3 Gaucher cells had significantly increased anisotropy 
values. Also, from the order parameter and apparent microviscosity, 
it can be concluded that there was decreased membrane fluidity for 
the neuronopathic (acute and subacute) forms of Gaucher disease. In 
the infant form of type 1 disease investigated, there was no signif-
icant difference in anisotropy, and thus membrane fluidity, from normal 
cells. As compared to normal adult fibroblast membranes, type 1 
Gaucher cells exhibited a variability of data with respect to ani-
sotropy measurements and thus membrane fluidity. On the average, 
type 1 Gaucher cells exhibit no difference in membrane fluidity as 
compared to normal cells; however, for one of the cell lines (AdG 
1470), there was significant increase in anisotropy value as compared 
to normal cells. This difference in steady-state fluorescence ani-
sotropy in the various type 1 Gaucher cells could be reflecting the 
heterogeneity found among adult non-neuronopathic forms of Gaucher 
TABLE 7.--Fluorescence Polarization (P), Anisotropy <rs), Membrane Viscosity (n), Limiting Anisotropy(r
00
), 
and Order Parameter (S) of Normal and Gaucher Diseased Fibroblasts at 25°C 
Nml Infant 
GM 302A (n=3) 
Type 1 Infant 
GM 4394 (n=3) 
Type 2 Infant 
a. InG 1247 (n=5) 
b. GM 877 (n=3) 
Type 3 Juvenile 
JuvG (n=3) 
Nml Adult 
a. GM 3440 (n=4) 
b. NmlF (n=3) 
Type 1 Adult 
a. AdG 119a (n=3) 
b. AdG 1470 (n=4) 
p 
0.251 + .007 
0.263 + .012 
0.303 + .016** 
0.311 + .019* 
0.294 + .006* 
0.270 + .015 
0.279 + .010 
0.262 + .006 
0.301 + .010*** 
0.182 + .006 
0.192 + .009 
0.225 + .013** 
0.231 + .016* 
0.216 + .005* 
0.198 + .012 
0.205 + .008 
0.191 + .004 
0.223 + .009*** 
-n (Poise) 
2.43 
2. 71 
3.94 
4.23 
3.55 
2.90 
3.13 
2.68 
3.85 
r 
00 
0.143 
0.156 
0.200 
0.208 
0.188 
0.164 
0.173 
0.155 
0.197 
s 
0.628 
0.656 
0.743 
0.758 
o. 721 
0.673 
0.692 
0.654 
0.738 
Each value represents mean + standard deviation, n represents the number of separate determinations. 
*P<0.01 
**P<0.001 as compared with normal infant 
***P<0.01 as compared with normal adult using Student's two-tailed t test. 
disease. Note, there also existed a difference between the normal 
adult and infant cell lines, where there was a significant increase 
of fluidity in normal infants as compared to normal adults. 
Figures 16 and 17 show the effect of increasing temperature 
on fluorescence anisotropy values for normal and diseased cells and 
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it can be seen, as a general result, that as the temperature increases, 
the anisotropy value decreases. Therefore, the membrane fluidity 
increases with increasing temperature for all membranes. As the first 
figure shows, type 2 and type 3 Gaucher cells, which had a significant 
difference from normal inf ant cells with respect to anisotropy values 
at 2soc, also exhibited a difference in fluidity at all the tempera-
tures. Each point on the curve represents an average of two different 
experiments at the specified temperature. The determination for type 
2 Gaucher cells was done using both the cell lines InG 1247 and GM 
877; for type 3 Gaucher cells, the cell line labeled Juv G was used. 
This figure then shows that at all temperatures between 4-40°C, there 
was decreased fluidity of type 2 and type 3 Gaucher cells. This con-
clusion also holds true for the type 1 Gaucher cell line (AdG 1470) 
which had a significant difference from normal adult cells with respect 
to anisotropy value at 2s 0 c. Therefore, there was decreased membrane 
fluidity in type 1 Gaucher fibroblasts at all temperatures between 
4-40°C. From these temperature studies, one can evaluate if there 
are any bulk lipid phase transitions by looking at the Arrhenius plots 
of log (anisotropy) versus l/temperature. This is as shown in figures 
18 and 19. Figure 18 shows that there were no identifiable breaks· 
in the Arrhenius plots of normal infant fibroblasts, type 2 and type 
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Fig. 16. Temperature dependence of anisotropy of DPH in 
normal infant (e) and Gaucher diseased fibroblasts--type 2 (o) and 
type 3 (~). Each point is the average of two separate temperature 
scans. 
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3 Gaucher cells; thus implying that, between 4-40°C, there were no 
bulk lipid phase transitions in fibroblast membranes as judged by 
steady-state fluorescence anisotropy using the probe DPH. 
d (log r ) 
The slope (d (l/T) 8 ), as derived from linear least square fit 
(Table 8), and the intercept on the ordinate for the Arrhenius curve 
for normal infant fibroblasts were different from that of type 2 and 
type 3 Gaucher cells. Figure 19 shows that using normal adult cells 
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(GM 3440) and type 1 Gaucher cells (AdG 1470) there were no bulk lipid 
phase transitions. Again, the slope and the ordinate intercept were 
different in normal adult cells as compared with type 1 Gaucher cells. 
Neutral Lipid Content of Normal and 
Diseased Cells 
Figure 20 shows the HPTLC plate obtained using the separation 
system listed in Materials and Methods. From this, the total amounts 
of cholesterol, free fatty acid, triglycerides, and cholesterol ester 
were determined. It is to be noted that once the area was obtained 
for each spot for the standard, a standard curve was determined for 
total area versus amount of lipid spotted and linear least square 
fit was used to determine the best fit, and from it the sample amount 
was determined. A densitometric pattern for one of the lanes is given 
in the same figure. Each neutral lipid is expressed as µg/mg of 
protein. As can be seen from Table 9, there were no differences be-
tween normal and Gaucher cells with respect to cholesterol and free 
fatty acid content. There was a considerably decreased amount of 
cholesterol ester in all three types of Gaucher disease fibroblasts 
as compared with normal fibroblasts. It seems that type 1 Gaucher 
TABLE 8.--Slope, Ordinate Intercept, and Correlation Coefficient 
Derived from Arrhenius Plots of Log (Fluorescence Anisotropy) 
versus [Temperature (OK)]-1 
Cell Type Slope Intercept Corr. Coe ff. 
Nml Infant -2.68 0.0059 0.99 
Type 2 Infant -2.40 0.0051 0.99 
Type 3 Juvenile -2.30 0.0048 0.97 
Nml Adult -2.98 0.0065 0.99 
Type 1 Adult -2.44 0.0052 0.98 
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Fig. 20. HPTLC chromatogram of neutral lipids isolated from 
fibroblasts. 
(a) Lanes 1-4, 5-20 µl standard neutral lipid mixtures (see Methods). 
Lane 5, sample from normal adult fibroblasts (GM 3440). Lane 6, 
sample from type 1 adult Gaucher diseased fibroblasts (AdG 1470). 
Lane 7, sample from normal infant fibroblasts (GM 302A). Lane 8, 
sample from type 1 infant Gaucher diseased fibroblasts (GM 4394). 
Symbols used: A, cholesterol; B, free fatty acid; C, triglyceride: 
D, cholesterol ester. 
(b) Densitometric scan of lane 7 in (a). Symbols defined as above. 
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TABLE 9.--Neutral Lipid Composition of Normal and Gaucher Diseased Fibroblasts 
Cholesterol Fatty Acid Triglycerides Cholesterol Ester 
Nml Infant 
GM 302A (n=3) 39.63 + 15.75 1.52 + 0.58 35.09 + 4.24 28. 38 + 9.02 
-
Type 1 Inf ant 
GM 4394 (n=3) 29.39 + 12.20 1.07 + 0.69 14.22 + 6.31** 9.46 + 4.94* 
- -
Type 2 Infant 
a. InG 1247 (n=3) 35.12 + 19.42 1.19 + 1.16 21. 75 + 16.65 14.35 + 9.97 
b. GM 877 (n=3) 66.12 + 20. 85 1.64 + 0.84 29.64 + 19.44 10.92 + 11.60 
Type 3 Juvenile 
JuvG (n=3) 44.66 + 27.52 0.62 + 0.37 32.77 + 15.52 13.13 + 6.75 
Nml Adult 
GM 3440 (n=4) 35.62 + 13.41 0.99 + 0.95 32.04 + 18.07 22.24 + 14.91 
Type 1 Adult 
a. AdG 119a (n=2) 20.36 - 22.45 0.16 - 0.18 9.22 - 12.34 1.91 - 3.86 
b. AdG 1470 (n=3) 37.39 + 23.53 0.62 + 0.65 12.20 + 6. 77 9. 71 + 1.89 
- -
Each neutral lipid is expressed as µg/mg of protein. Each value represents mean ±.. standard deviation. 
*P<0.05, **P<0.01 as compared with normal infant using Student's two-tailed t test. 
n represents the number of separate determinations. 
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cells had a much more decreased content of cholesterol ester content 
as compared to type 2 and type 3 Gaucher fibroblasts. It is also 
interesting to note that only in type 1 Gaucher disease cells there 
was also a decrease in the triglyceride content as compared to normal 
cells; whereas, both type 2 and type 3 Gaucher cells had triglyceride 
content within the normal range. With respect to the type 1 Gaucher 
infant cell line (GM 4394), there was a significant decrease in both 
the triglyceride and cholesterol ester content as compared to normal. 
Phospholipid Content of Normal and Diseased Cells 
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Figure 21 shows the HPTLC plate of phospholipids obtained 
using the separation system listed in Materials and Methods. It can 
be seen that the major lipids in fibroblasts were sphingomyelin, phos-
phatidylcholine, phosphatidylserine, phosphatidylinositol, and phos-
phatidylethanolamine. From the standards spotted, standard least-
linear curves (total area versus amount of lipid) were determined, 
and from it the amount of unknown lipids quantitated. A densitometric 
pattern for one of the lanes is shown in the same figure. The results 
for the phospholipid content for various cell lines are summarized in 
Table 10. As can be seen from this table, there seemed to be no dif-
ference between normal and Gaucher cells with respect to phosphatidyl-
serine, phosphatidylinositol, and phosphatidylethanolamine. As com-
pared to normal infant cells, type 1 Gaucher infant cells did not 
have an altered sphingomyelin content; however, there seemed to be a 
trend for decreased phosphatidylcholine content. Type 2 Gaucher cells 
had, on the average, a decreased amount of sphingomyelin and phospha-
Fig. 21. HPTLC chomatogram of phospholipids isolated from 
fibroblasts. 
(a) Lanes 1-4, 5-20 µl standard phospholipid mixtures (see Methods). 
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Lanes 5 and 6, samples from normal adult fibroblasts (GM 3440). 
Lane 7, sample from normal infant fibroblasts (GM 302A). Lane 8, 
sample from type 1 adult Gaucher diseased fibroblasts (AdG 1470). 
Symbols used: A, sphingomyelin; B, phosphatidylcholine; C, 
phosphatidylserine; D, phosphatidylinositol; E, phosphatidyl-
ethanolamine. 
(b) Densitometric scan of lane 7 in (a). Symbols defined as above. 
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TABLE 10.--Phospholipid Composition of Normal and Gaucher Diseased Fibroblasts 
SPM PC PS PI PE 
Nml Inf ant 
GM 302A (n=3) 101.62 + 32.56 257.37 + 72.00 24.54 + 18.13 7.18 + 1.93 103.5 + 62.30 
-
Type 1 Inf ant 
GM 4394 (n=3) 90.70 + 6. 71 126.30 + 55.30 10.47 + 2.17 4.46 + 0.60 69.31 + 18.03 
-
Type 2 Infant 
a. InG 1247 (n=3) 24.39 + 4.62 122.93 + 48.82 11.35 + 7.05 8.04 + 5.75 71.87 + 6.33 
- -b. GM 877 (n=3) 82.24 + 8.32 116.47 + 51.09 12.10 + 6.76 3.40 + 1.32 152.40 + 111.62 
-
Type 3 Juvenile 
Juv G (n=3) 43.18 + 21.89 172.60 + 101.62 20.15 + 5.16 5.14 + 2.51 53.79 + 16.86 
-
Nml Adult 
GM 3440 (n=3) 100.59 + 37.90 212.23 + 33.52 13.42 + 14.31 3.47 + 2.32 102.97 + 46.29 
-
Type 1 Adult 
a. AdG 119a (n=2) 19.92 - 33.9 65.5 - 81.6 12.5 - 21.52 3.84 - 10.8 20.76 - 56.80 
b. AdG 1470 (n=3) 108.45 + 70.57 208.37 + 58.28 37.46 + 39.98 10.85 + 7.24 128.84 + 45.29 
- -
Each Phospholipid expressed as µg/mg of protein. Each value represents mean + standard deviation. Control 
and Gaucher phospholipid values did not differ significantly by Student's two-tailed t test. Definition 
of symbols: SPM, sphingomyelin; PC, phosphatidylcholine; PS, phosphatidylserine; PI, phosphatidylinositol; 
PE, phosphatidylethanolamine. n represents the number of separate determinations. \.0 
N 
tidylcholine content as compared to normal infant cells. In type 3 
Gaucher cells, there was no change in phosphatidylcholine content; 
however, there seemed to be decreased amounts of sphingomyelin. It 
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is interesting to note that the phospholipid content of both normal 
adult and normal inf ants were approximately the same. As compared to 
normal adult cell lines, one of the cell lines (AdG 119a) had decreased 
amounts of sphingomyelin and phosphatidylcholine; whereas, the AdG 
1470 cell line had approximately the same phospholipid composition as 
that of normal cells. This variability in type 1 cells could possibly 
be due to the heterogeneity that is found among this disease. 
Ceramide Content of Normal and Diseased Cells 
Figure 22 shows the HPTLC plate of ceramide obtained using 
the separation system listed in the Materials and Methods. From this 
technique, we were able to quantitate the ceramide content of normal 
and Gaucher diseased fibroblasts. It can be seen from Table 11 that 
as compared to normal infant cells, types 1, 2, and 3 Gaucher cells 
had approximately the same content of ceramide. This also held true 
for type 1 adult Gaucher cells as compared to normal adult fibro-
blasts. Ceramide content in cells was 1/10 to 1/50 the concentration 
of cholesterol levels. 
Effect of Monensin on Normal Fibroblast Lipids 
Table 12 shows the effect of monensin on neutral lipids, phos-
pholipids, and ceramide as compared to control cells (methodology 
described as previously). This table describes both the total amounts 
of each lipid as well as the counts observed after labeling with (3H) 
Fig. 22. HPTLC chromatogram of ceramide containing lipid 
fraction, isolated from fibroblasts. Lanes 1-4, 5-20 ~l standard 
ceramide (see Methods). Lane 5, sample from type 1 adult Gaucher 
diseased fibroblasts (AdG 1470). Lanes 6-8, samples from type 3 
juvenile Gaucher diseased fibroblasts (JuvG). Symbols used: A, 
phospholipids; B, ceramide; C, cholesterol; D, cholesterol ester 
(migrating with the solvent front). 
94 
95 
-
-
. 1 , 2 . 3 4 . 5 6 7 8 
TABLE 11.--Ceramide Composition of Normal and Gaucher Diseased 
Fibroblasts 
Ceramide 
Nml Infant 
GM 302A (n=3) 2.75 + 1.66 
Type 2 Infant 
GM 877 (n=3) 1.17 + 0.81 
Type 3 Juvenile 
JuvG (n=3) 2.73 + 0.49 
Nml Adult 
GM 3440 (n=3) 0.98 + 0.08 
Type 1 Adult 
AdG 1470 (n=3) 2.33 + 1.62 
Amount of ceramide expressed as µg/mg of protein. Each value repre-
sents mean + standard deviation. Control and Gaucher ceramide values 
did not differ significantly by Student's two-tailed t test. n repre-
sents number of separate determinations. 
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TABLE 12.--Effect of Monensin on Normal Fibroblast (GM 3440) Lipids 
Total Lipid (µg/mg of protein) Radioactivity (dpm/mg of protein) 
M+ M- M+ M-
Neutral Lipids 
Cholesterol 60.94 + 7.42 76.67 + 12.24 14313 + 4004** 2948 + 844 
- - -Free Fatty Acids 2.65 + 0.46* 1. 70 + 0.38 10341 + 799* 3663 + 1185 
Triglycerides 39.55 + 3.44 50.64 + 11.26 61834 + 12726 38700 + 12892 
Cholesterol Ester 4.15 + 2.18** 14.91 + 3.84 482 + 111 ** 3275 + 790 
-
Phospholipids 
Sphingomyelin 65.13 + 6.85 78.33 + 29.12 12723 + 3234 11125 + 2947 
-Phosphatidylcholine 136.23 + 
-
6.67* 224.13 + 44.41 137013 + 7730** 55424 + 13277 
Phosphatidylserine 14.99 + 1.33** 4.76 + 2.28 10909 + 1214** 5012 + 1880 
- -Phosphatidylinositol 5.16 + 0.65 4.83 + 2.56 1259 + 298* 627 + 248 
-Phosphatidylethanolamine 235.33 + 52.14 247.52 + 67.81 18657 + 3074** 7677 + 1716 
Ceramide 0.45 + 0.20 0.41 + 0.07 44.94 + 17.33 46.32 + 15.00 
Each value represents mean of three separate trials ±.. standard deviation. M+ represents monensin treated 
cells; whereas, M- represents non-monensin treated cells. 
*P<0.05; **P<0.01 as compared with non-monensin treated cells using Student's two-tailed t test. 
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acetate for 18 hours in the same cells labeled with either monensin 
(in ethanol) or without monensin (but an equal amount of ethanol). 
With respect to total lipids, there was a significant decrease 
in the amount of cholesterol ester and phosphatidylcholine content 
in monensin treated cells. There was significant increase in the free 
fatty acid and phosphatidylserine content of monensin treated f ibro-
blasts. The amounts of other lipids in monensin treated cells were 
comparable to that of non-monensin treated cells. In relation to 
incorporation of (3H) acetate into neutral lipids, there was decreased 
incorporation of the label into cholesterol ester; whereas, there 
was increased incorporation into cholesterol, free fatty acids, and 
triglycerides. The incorporation of the tritiated label was increased 
in phosphatidylcholine, phosphatidylserine, phosphatidylinositol and 
phosphatidylethanolamine; whereas, there was no change in sphingomye-
lin. Similar to sphingomyelin, ceramide did not have an altered incor-
poration of the label when treated with monensin. Some of the values 
in Table 12 differ from the previous tables since even the controls 
are treated with ethanol. 
Phospholipid and Cholesterol Ester Fatty 
Acid Analysis 
The fatty acid methyl esters of individual lipids were deter-
mined as described in Materials and Methods. Table 13 shows the fatty 
acid composition of phosphatidylcholine of fibroblasts of normal and 
diseased subjects. As can be seen from this table, the major saturated 
fatty acids for phosphatidylcholine were C14:0, C16:0, C18:0, and 
C22:0, whereas, the unsaturated fatty acids were mainly C16:1, C18:1, 
99 
TABLE 13.--Fatty Acid Composition of Phosphatidylcholine of Fibroblasts 
(Weight %) 
Adult Infant 
GM 3440 AdG 1470 GM 302A InG 1247 GM 877 
Fatty Acid (Nml) (Type 1) (Nml) (Type 2) (Type 2) 
14:0 1.3 0.8 2.7 3.4 2.7 
16:0 24.6 26.4 39.7 25.7 29.6 
16:1 4.7 5.8 1. 7 7.8 3.6 
18:0 25.3 25.0 26.7 22.9 19.4 
18:1 30.9 25.3 16.5 25.8 24.9 
18:2 1.3 0.7 0.9 1.9 1.1 
18:3 1.3 0.7 1.5 1.6 1.3 
20:4 9.8 13.3 9.5 8.3 2.7 
22:0 0.8 2.3 0.5 2.4 2.0 
24:0 -a 10.0 
aTrace amounts. 
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the same; this was also true for type 2 Gaucher cells (InG 1247) as 
compared with normal infants. In GM 877, type 2 Gaucher cells, there 
was increase in amounts of C24:0 as compared to normal cells. 
Table 14 shows the fatty acid composition of phosphatidyl-
ethanolamine of the various cell lines. It can be seen in this table 
that there was increased amount of Cl8:1 in normal adult fibroblast 
as compared with type 1 Gaucher cells. Whereas, there was considerable 
increased amount of Cl6:0, Cl8:0 and decreased amount of Cl8:1 and 
C20:4 in normal cells as compared with type 2 Gaucher cells (InG 
1247). In another type 2 Gaucher cell line, GM 877, there was de-
creased amount of Cl8:1 and decreased amount of Cl8:0 as compared 
with normal infant cells. It should also be noted that the fatty 
acid composition of phosphatidylethanolamine was different from that 
of phosphatidylcholine. 
Table 15 shows the fatty acid composition of sphingomyelin of 
the various fibroblastic cell lines. Type 1 Gaucher fibroblasts 
sphingomyelin had a decreased amount of C16:0 and an increased amount 
of Cl8:0 and C22:0 as compared to normal adult sphingomyelin fatty 
acids. Sphingomyelin from Type 2 Gaucher fibroblast (InG 1247) had 
a considerable increased amount of C16:1 and C24:0 and a decreased 
amount of C16:0 and Cl8:0 as compared to normal. In another type 2 
Gaucher cell line, GM 877, there was an increase in amount of Cl6:1 
and some decrease in C18:0. It is also to be noted that there was a 
difference between normal adult and infant cells with respect to their 
sphingomyelin fatty acid content. And also, the fatty acid composition 
Iii 
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TABLE 14.--Fatty Acid Composition of Phosphatidylethanolamine of 
Fibroblasts 
(Weight %) 
Adult Infant 
GM 3440 AdG 1470 GM 302A InG 1247 GM 877 
Fatty Acid (Nml) (Type 1) (Nml) (Type 2) (Type 2) 
14:0 -a 1.9 2.4 
16:0 9.3 6.6 19.7 18.0 
16:1 0.8 1.4 2.4 
18:0 27.9 36.0 42.6 28.9 32.2 
18:1 23.6 14.2 15.5 23.5 30.0 
18:2 4.5 3.2 1.9 
18:3 5.2 1.3 
20:4 38.4 43.2 9.2 29.5 8.8 
Other 6.7 8.3 3.0 
8 Trace amounts. 
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TABLE 15.--Fatty Acid Composition of Sphingomyelin of Fibroblasts 
(Weight %) 
Adult Inf ant 
GM 3440 AdG 1470 GM 302A InG 1247 GM 877 
Fatty Acid (Nml) (Type 1) (Nml) (Type 2) (Type 2) 
16:0 52.8 23.7 48.7 27.2 49.2 
16:1 2.7 
-
a 31.3 13.9 
18:0 18.8 42.6 18.1 4.4 10.9 
18:1 10.5 4.2 
22:0 15.2 29.5 13.8 9.8 9.3 
24:0 19.4 27.4 16.7 
aTrace amounts. 
of sphingomyelin was different from that of phosphatidylcholine and 
phosphatidylethanolamine. 
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Table 16 shows the fatty acid composition of phosphatidylserine 
of various fibroblastic cell lines. It can be seen from the table 
that type 1 and type 2 Gaucher fibroblast phosphatidylserine fatty 
acids had an increased amount of Cl4:0, Cl6:0, Cl6:1, and Cl8:1 as 
compared to normal adult; whereas, there was decreased amounts of 
Cl8:0 and C20:4. Table 17 shows the fatty acid composition of phos-
phatidylinositol and it can be seen that there was an increased amount 
of Cl6:0, Cl6:1, and Cl8:1, whereas, there was decreased amount of 
Cl4:0 and Cl8:0 in type 2 Gaucher cells. 
The fatty acids of cholesterol esters were also analyzed for 
normal and Gaucher diseased cell lines. Table 18 shows that the major 
saturated fatty acids for cholesterol ester were Cl4:0, Cl6:0, and 
Cl8:0, and the major unsaturated fatty acids were Cl6:1, Cl8:1, Cl8:2, 
and Cl8:3. As compared to normal adult cells, type 1 Gaucher cells 
(AdG 1470) had a dramatic increase in the amount of Cl4:0 and a reduc-
tion of Cl8:1. As compared with normal infant cholesterol ester fatty 
acid, type 1 infant Gaucher cells had a relative increase in Cl6:0, 
and Cl8:1. Type 2 infant Gaucher cells had an increased amount of 
Cl6:0, Cl6:1, Cl8:0 and Cl8:1. Type 3 juvenile Gaucher cells had an 
increased amount of Cl8:1 and Cl8:2. 
In Table 18 it is also shown that there was an unidentified 
peak in cholesterol ester from normal cell lines which was not observed 
in all three types of Gaucher disease. Hydrogenation on the fatty 
acid methyl esters of normal infant cholesterol ester was performed 
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TABLE 16.--Fatty Acid Composition of Phosph~tidylserine of Fibroblasts 
(Weight %) 
Adult Infant 
GM 3440 AdG 1470 GM 302A InG 1247 GM 877 
Fatty Acid (Nml) (Type 1) (Nml) (Type 2) (Type 2) 
14:0 -a 3.2 
16:0 14.1 n.d.b 29.6 18.4 
16:1 5.8 1.9 11.6 
18:0 49.0 32.4 24.7 34.2 
18:1 5.0 14.4 25.6 13.5 
20:4 45.0 30.1 18.2 22.3 
aTrace amounts. 
bn.d. denotes not determined. 
TABLE 17.--Fatty Acid Composition of Phosphatidylinositol of 
Fibroblasts 
(Weight %) 
Adult Infant 
GM 3440 AdG 1470 GM 302A InG 1247 
Fatty Acid (Nml) (Type 1) (Nml) (Type 2) 
14:0 -a n.d.b 19.S 
16:0 7.0 39.6 
16:1 6.0 
18:0 50.0 60.2 36.3 
18:1 2.4 4.3 
20:4 47.6 13.2 13.7 
aTrace amounts. 
bn.d. denotes not determined. 
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TABLE 18.--Fatty Acid Composition of Cholesterol Ester of Fibroblasts 
(Weight %) 
Adult Inf ant 
Fatty GM 3440 AdG 1470 GM 302A GM 4394 InG 1247 JuvG 
Acid (Nml) (Type 1) (Nml) (Type 1) (Type 2) (Type 3) 
14:0 1.9 26.7 10.2 15.1 11.9 15.2 
16:0 23.5 21.9 16.2 21.3 24.7 11.5 
16:1 7.3 1.4 2.4 5.9 7.3 4.3 
18:0 16.8 26.3 23.6 21.5 31.3 22.5 
18:1 39.4 4.9 10.2 21.5 17.9 21.2 
18:2 2.7 9.7 10.7 14.1 6.8 25.2 
18:3 2.9 9.2 _a 0.5 
Other 6.5 --b 26.7 
aTrace amounts. 
b Not detectable. 
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to check if this unidentified fatty acid had any double bonds. Hydro-
genation yielded a peak in the C24:0 region. Thus, it is most likely 
that cholesterol ester of normal fibroblasts have a unique unsaturated 
fatty acid, C24 (number of double bonds unidentifiable), which is 
not found in Gaucher Disease. 
Membrane Fluidity and Correlation with 
Various Lipid Ratios 
Table 19 shows the cholesterol/phospholipid (mole/mole) and 
cholesterol/sphingomyelin (mole/mole) ratio for individual cell lines, 
along with the fluorescence anisotropy values. It can be seen that 
there was an increase in the aforementioned lipid ratios of cells 
from type 2 and type 3 Gaucher disease, along with significant decrease 
in fluidity; whereas, for type 1 infant cells, there was no alteration 
in membrane fluidity, along with relatively little change in the rel-
evant lipid ratios. With respect to normal adult cells, type 1 adult 
Gaucher cells exhibited a variability of data with respect to membrane 
fluidity as well as the lipid ratios. In the cell line AdG 119a, 
there was no altered membrane fluidity; however, there seemed to be 
an increase in cholesterol/phospholipid and cholesterol/sphingomyelin 
ratios. With respect to the cell line AdG 1470, which had an increased 
anisotropy (decreased membrane fluidity), there was no increased 
cholesterol/phospholipid or cholesterol/sphingomyelin ratio encoun-
tered. Sphingomyelin/phosphatidylcholine as well as sphingomyelin/ 
phospholipid ratios were also determined and no correlation with the 
fluidity measurements could be observed. It is interesting to note 
that even though there was decreased fluidity in normal adult fibro-
TABLE 19.--Fluorescence Anisotropy Values with Relevant Lipid Ratios 
rs C/PL C/SPM SPM/PL SPM/PC 
Nml Inf ant 
GM 302A 0.182 + .006 0.164 0.78 0.206 0.395 
Type 1 Infant 
GM 4394 0.192 + .009 0.166 0.64 0.301 o. 718 
-
Type 2 Infant 
a. InG 1247 0.225 + .013 0.300 2.88 0.102 0.198 
b. GM 877 0.231 + .016 0.361 1.61 0.224 0.706 
-
Type 3 Juvenile 
JuvG 0.216 + .005 0.300 2.06 0.146 0.250 
-
Nml Adult 
a. GM 3440 0.198 + .012 0.164 0.70 0.232 0.474 
b. Nml F 0.205 + • 008 n.d • n.d. n.d. n.d. 
Type 1 Adult 
a. AdG 119a 0.191 + .004 0.260 1.60 0.166 0.373 
b. AdG 1470 0.223 + .009 0.152 0.68 0.220 0.520 
Definition of symbols: 
C/PL, Cholesterol (mol); C/SPM, Cholesterol (mol) ; SPM/PL, SEhingomielin (mol) 
Phospholipid (mol) Sphingomyelin (mol) Phospholipid (mol) 
SPM/PC, SEhingomielin (mol) f--' 
Phosphatidylcholine (mol) 0 00 
Each ratio is the ratio of the means. 
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blasts as compared with normal infant fibroblasts, there was no alter-
ation in the cholesterol/phospholipid or cholesterol/sphingomyelin 
ratios. 
CHAPTER V 
DISCUSSION 
Relevance of Membrane Fluidity 
DPH Incorporation 
Cultured human skin fibroblasts have a measurable membrane 
fluidity via steady-state fluorescence anisotropy using the fluorescent 
hydrocarbon probe DPH. DPH gets incorporated into fibroblast membranes 
and gives characteristic excitation and emission spectra with a rel-
ative excitation maximum at 360 nm and emission maximum at 426 nm. The 
lipid-probe molar ratio is calculated to be approximately 104-105, 
which is well above the range to avoid energy transfer and excimer 
formation between probe molecules; this is since Kawato et al. (1977) 
have recommended a lipid-probe molar ratio of at least 103 to avoid 
these fluorescence phenomenon. It can also be seen in this study 
that fibroblasts have an intrinsic fluorescence which is similar in 
all the cell lines (normal and Gaucher) investigated. The emission 
and excitation spectra are similar for both normal and diseased f ibro-
blasts. They are also comparable to spectra obtained by other in-
vestigators on fibroblasts as well as other types of cells (Shinitzky 
& Inbar, 1974; Van Blitterswijk et al. 1977; Lakowicz & Sheppard, 
1981; Schroeder et al., 1984). 
It is believed that once DPH gets incorporated into biological 
110 
membranes, it aligns itself parallel to the fatty acyl chains in the 
middle of the bilayer (Lentz et al., 1976a,b). In intact cells, the 
fluorescent probe gets incorporated not only in plasma membranes, 
but also in cytoplasmic membranes. The exact amount of probe into 
each membrane component is not known at this moment. However, it is 
believed that in short term incubation (few minutes), fluorescence 
parameters of DPH characterize the plasma membrane; whereas, long 
term incubation (up to 90 minutes) characterize both the plasma mem-
brane and intracellular membrane lipid characteristics (Pagano, et 
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al., 1977; Bouchy et al., 1981). It is possible to calculate plasma 
membrane fluidity in intact cells labeled with DPH by selective quench-
ing, nonradiative energy transfer, of the fluorescence emitted from 
the plasma membrane after tagging the cell with an impermeable membrane 
electron acceptor such as 2,4,6-trinitrobenzene sulfonate (TNBS) (Grun-
berger et al., 1982). 
Fluorescence Anisotropy 
In this study, the objective was to determine the membrane 
fluidity of physiological viable Gaucher cells and to compare them 
to normal fibroblasts and relate this to the lipid abnormalites which 
occur. As can be seen from Figure 7, the fluorescence anisotropy of 
both normal and diseased cells remain relatively constant for the 
times investigated implying that once the probe gets incorporated 
into the lipid pools, the average distance between the embedded DPH 
molecules is high enough to avoid intermolecular transfer of excitation 
energy (Shinitzky & Inbar, 1974, 1976). It also implies that for 
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all the times investigated, the compartmentalization of DPH in plasma 
membrane as well as the cytoplasmic membranes is approximately the 
same in the cell. It can also be concluded that the probe incorpora-
tion in normal and diseased cells is approximately the same in each 
compartment since there is no change in fluorescence anisotropy 
measurements with respect to time of incubation of DPH,taking into 
account the freely diffusing property of DPH (Shinitzky & Barenholz, 
1978). 
There are several methods which can be used to measure the 
fluorescence anisotropy of intact cells. One of the ways in which 
one can measure the anisotropy of intact cells is to treat the cells 
with the fluorei£ent probe and then detach them from the surface of 
the flask with EDTA or trypsin (Fuchs et al., 1975; DeLaat, et al., 
1977; Haggerty et al., 1978) and then use the suspension for fluidity 
measurements. It is possible that this may impair the lipid-protein 
interactions within the cell membrane. Therefore, another method 
has been set up for cultured cells where fluorescence polarization 
can be determined for cells attached to a glass substratum (DeLaat 
et al., 1977). Measurements of neuroblastoma cells with this method-
ology suggest that EDTA and trypsin detachment decrease the apparent 
membrane fluidity. The problem with this type of measurement seems 
to be that it does not correct for scattering which might occur due 
to the cells on the glass substratum. In this study, trypsinization 
treatment for detaching the cells was chosen since we wanted to compare 
the average fluorescence anisotropy of Gaucher fibroblasts with that 
of normal cells. Even though this might give an apparent fluidity 
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measurement, it is useful for comparison. Along with this, it is 
suspected that DPH in most biological membranes gives information 
regarding lipid-lipid interaction and, thus, trypsin treatment which 
destroys lipid-protein interactions may not have a significant effect 
on the fluidity measurements (Van Blitterswijk et al., 1977, 1981; 
Pottel et al, 1983). 
In relation to the discussion above, steady-state fluorescence 
measurements were performed on several fibroblastic cell lines from 
both normal and Gaucher disease subjects. At zs 0 c, as compared with 
normal infant cells (GM 302A), type 1 Gaucher cells (GM 4394) did 
not exhibit any difference in the fluorescence anisotropy value; thus, 
no change in microviscosity or order parameter was seen. In contrast 
to this, type 2 Gaucher cells (InG 1247 and GM 877) and type 3 Gaucher 
cells (JuvG) had a significant increase in the fluorescence anisotropy 
values and, thus, an increase in the apparent microviscosity as well 
as order parameter. As compared with normal adult fibroblasts, type 
1 Gaucher cells exhibited a variability of data. One of the cell 
lines, AdG 119a, did not exhibit any difference in the fluorescence 
anisotropy value; whereas, AdG 1470 did have a significantly increased 
fluorescence anisotropy value and thus the apparent microviscosity and 
order parameter were increased. 
Cholesterol/Phospholipid and 
Cholesterol/Sphingomyelin Ratios 
The decreased fluidity in type 2 and type 3 Gaucher disease 
cells also correlated well with the increased cholesterol/phospholipid 
and cholesterol/sphingomyelin ratios. With respect to type 1 infant 
Gaucher cells, there was no altered membrane fluidity as well as no 
change in the aforementioned lipid ratios. This finding of altered 
membrane fluidity correlating with altered cholesterol/phospholipid 
ratio agrees well with several investigators (Pottel et al., 1983; 
Shinitzky & Barenholz, 1978; Owen et al., 1982). The correlation 
of altered membrane fluidity with cholesterol/sphingomyelin ratio 
has not been presented previously. This correlation, however, seems 
justified in the sense that Patton (1970) has theoretically proposed 
a tight association between cholesterol and sphingomyelin in various 
biological membranes. The tight association between cholesterol and 
sphingomyelin has been shown to occur in model membranes (Barenholz 
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& Thompson, 1980). Also, Van Blitterswijk et al. (1981) have cor-
related an increased fluidity with a decreased cholesterol/phospho-
lipid ratio and, when this lipid ratio was constant, this was attribu-
ted to a decrease in sphingomyelin/total phospholipid ratio. These 
authors have also suggested that cholesterol is the primary important 
parameter and sphingomyelin is the secondary important factor deter-
mining structural order in biomembranes. Association of cholesterol 
and sphingomyelin also seems important in acanthocytes (which have 
decreased fluidity) as shown by Barenholz et al. (1981). These authors 
treated acanthocytes and normal erythrocyte membranes with cholesterol 
oxidase and noted that the fluidity of normal and diseased cells was 
approximately the same. This was then interpreted to mean that mem-
brane fluidity is dependent upon normal interactions of cholesterol 
with phospholipids (especially sphingomyelin and phosphatidylcholine). 
The association between cholesterol/phospholipid and choles-
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terol/ sphingomyelin ratios to membrane fluidity in adult type 1 
Gaucher cells did not follow the same pattern as that for the infant 
cells. For one of the cell lines which had no alteration in membrane 
fluidity as compared to normal adult cells, there seemed to have been 
some increase in the relevant lipid ratios. Whereas, for the type 1 
Gaucher cell line which had a significant increase in the fluorescence 
anisotropy measurement, there was no change in the lipid ratios. This 
could be explained in several ways. One explanation for the cell 
line AdG 119a having a constant anisotropy value with an increased 
cholesterol/phospholipid ratio could be that these cells have adapted 
their lipid concentration and phospholipid fatty acid such as to attain 
a "homeoviscous" state. This homeoviscous adaptation phenomenon has 
been observed in murine fibroblasts ( LM cells) where alteration in 
phospholipid polar headgroups led to alteration in fatty acid content 
of the phospholipids and along with this, no change in membrane flu-
idity occurred (Schroeder, 1978). 
It is useful to note that there was a significant difference 
between the steady-state fluorescence anisotropy value between normal 
infant fibroblasts and normal adult fibroblasts. The data presented 
in Table 7 show that normal infant fibroblasts had an increased mem-
brane fluidity, since there was a decreased value of fluorescence an-
isotropy. The decreased membrane fluidity of aged cells has been 
investigated previously in red blood cells by monitoring the electron 
paramagnetic resonance spectra of fatty acid spin labels incorporated 
into the membranes (Shiga et al., 1979). In this study by Shiga, 
et al., there was decreased membrane fluidity in aged human erythro-
cytes and it is suggested that this was in part due to lipid/protein 
ratio, the modified protein-lipid interaction and/or the influences 
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of diminished ATP content. There was no change in cholesterol/phos-
pholipid ratio observed. As another example of decreased membrane 
fluidity of aging membranes, Nagy et al. (1983) have shown by electron 
spin resonance, using modified stearic acid as a probe of synaptosomal 
membranes of rat brain cortex, that there is significantly decreased 
fluidity in older rat brain synaptosomes. Therefore, in this study, 
it is not surprising to find decreased fluidity in fibroblast membranes 
from adults as compared with normal infant cells. As can be seen 
from Table 19, there was no difference in the lipid ratios for normal 
adult and infant cells. The reason for the altered fluidity could 
possibly be altered lipid-protein interactions, amount of ATP changes 
(Shiga et al., 1979) or altered fatty acids of phospholipids. It is 
also to be noted that there was no passage effect observed in the 
evaluation of membrane fluidity of fibroblasts and is consistent with 
the findings of Haggerty et al. (1978). It is believed that fibro-
blasts have a limited lifetime in culture and they "age" with increas-
ing passage. However, this "aging" did not contribute significantly 
to alter the membrane fluidity (Table 20). 
Temperature Scans and Arrhenius Plots 
Along with the changes observed in fluorescence anisotropy 
and membrane fluidity of different fibroblastic cell lines at 2s 0 c, 
temperature studies also revealed the same results as that for 25°C. 
As compared with normal infant fibroblasts, type 2 and type 3 Gaucher 
TABLE 20.--Passaging of Fibroblasts and Its Effect on Fluorescence 
Anisotropy (rs) 
GM 3440 & Nml F 
(Nml Adult) 
Passage 
Number 
13 
14 
14 
17 
33 
34 
37 
0.287 
0.259 
0.277 
0.256 
0.269 
0.279 
0.289 
GM 302A 
(Nml Infant) 
Passage 
Number 
17 
18 
19 
0.259 
0.247 
0.247 
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cells had an increased fluorescence anisotropy values between 4-40°C. 
For the type 1 adult cell line which had an increased value of an-
isotropy at 25°C temperature scan study revealed the same phenomena 
occurring between 4-40°C. It is interesting to note that as the 
temperature increases, the fluorescence anisotropy decreases--which 
agree well with the observation that as the temperature increases, 
membrane fluidity increases as well. 
From the temperature scans and anisotropy values, Arrhenius 
plots (log rs versus I/temperature [°K]) were determined for normal 
and diseased cells. As could be determined from the Arrhenius plots, 
there were no phase transitions detectable in either normal or Gaucher 
diseased fibroblast membranes. This result is in accordance with that 
of Haggerty et al. (1978). It is not clear from literature which 
type of Arrhenius plots reveal the maximum information--e.g., log 
r 
rs, log n, log P or log (r0 -1)-l versus 1/T (Shinitzky & Baren-
holz, 1974; Fuchs et al., 1975; Haggerty et al., 1978; Shinitzky & 
Barenholz, 1978; Boitema et al., 1983; Berlin & Sainz, 1984; Nagatomo 
et al., 1984). In this report, log rs versus 1/T curves were plotted 
and no phase transitions could be detected. Log n, log P, and log 
r 
(r0 -1) were also used in the ordinate value for Arrhenius plots 
and, again, no phase transitions could be detected. The possible 
reason for not detecting any phase transition, and thus lipid phase 
separation could be that DPH gives some average information of the 
molecular heterogenous bilayer (Shinitzki & Barenholz, 1978). Also, 
Ladbroke et al. (1968) have shown that cholesterol diminishes and 
eventually abolishes the endothermic lipid phase transition of phos-
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pholipids. Concentration of 10 mole percentage cholesterol eliminates 
the pre-transition of phosphatidylcholines. In biological membranes, 
therefore, cholesterol could be interacting with phospholipid fatty 
acyl chains in such a way as to abolish phase transition (Barenholz 
et al., 1981). It also seems worth to note that cholesterol and phos-
pholipids are probably interacting in a similar fashion in both normal 
and Gaucher diseased cells such as to give no lipid phase transitions 
between 4-40°C. 
The differences of slopes in Arrhenius plots of normal from 
Gaucher diseased fibroblasts probably implies that the flow activation 
energy of lipids in membranes is different (Shinitzky & Barenholz, 
1978). The change in the intercept of normal versus Gaucher cells 
reflects the fact that Gaucher cells have an increased microviscosity 
at all temperatures between 4-40°C. 
As an interesting further study, it would be useful to study 
the fluidity of various fibroblast membranes from normal cells and 
compare this to membranes from Gaucher fibroblasts. In particular, 
attention must be given to plasma membrane fluidity since much of 
the intact cell membrane fluidity arises from these membranes. Also, 
lysosomal membrane fluidity should be discerned since Gaucher disease 
is a lysosomal membranous enzymopathy. Lipid composition of plasma 
membranes and lysosomal membranes must also be investigated and cor-
related with membrane fluidity measurements. The fluidity measurements 
should also be carried out in several related lysosomal enzymopathy 
of sphingolipids to determine if there are membrane abnormalities in 
these diseases and if any correlations occur. 
Relevance of Neutral Lipid, Phospholipid, 
and Ceramide Composition of Fibroblasts 
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It has been reported by Saito and Rosenberg (1984a) that Gaucher 
disease fibroblasts do not have an increased accumulation of gluco-
sylceramide as compared with normal cells (1.23 :!:_0.08 nmole/mg of 
protein for Gaucher cells, 1.11 + 0.48 nmole/mg of protein for normal 
infant cells). However, there is some alteration of higher neutral 
glycosphingolipids as well as gangliosides in Gaucher cells. Until 
recently, the quantity of other lipids in Gaucher diseased fibroblasts 
(neutral lipids, phospholipids, and ceramide) has not been investi-
gated. Abnormalities in phospholipid have been suggested by Barton 
and Rosenberg (1974) and cholesterol content in one of the cell lines 
from Gaucher disease has been determined by Warren et al. (1976) as 
discussed previously. 
Neutral Lipid Composition 
Table 9 shows the neutral lipid analysis for normal and Gaucher 
diseased cells. Neutral lipids were analyzed by high performance 
thin-layer chromatography and densitometry. The developing solvent 
system used has not been reported previously and it was able to discern 
between cholesterol, free fatty acids, triglycerides, and cholesterol 
ester. From this methodology, the amount of each neutral lipid was 
determined. As compared with normal infant fibroblasts, type 1 Gaucher 
cells had significantly decreased values of triglycerides and choles-
terol ester; whereas, there was no difference with respect to the 
cholesterol and free fatty acid content. Type 2 inf ant cells had 
approximately the same content of cholesterol, free fatty acid, and 
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triglycerides; whereas, there may have been some decrease in the cho-
lesterol ester content (not statistically significant). Type 3 cells 
had a similar neutral lipid content as that of type 2 fibroblasts. 
Normal adult cells did not exhibit any difference, in neutral lipid 
content, from normal infant cells. Type 1 adult cells had decreased 
triglyceride and ~holesterol ester content as compared to normal 
adult. This finding that cholesterol ester may be decreased in all 
three types of Gaucher cells, and triglyceride decreased in type 1 
Gaucher disease has not been reported previously. Therefore, even 
though there is decrease in activity of only one enzyme (S-glucosidase) 
in Gaucher disease which leads to abnormal glycosphingolipid content, 
there are other lipid abnormalities which can also occur. This is 
similar to Niemann-Pick disease, type D, in which there is deficiency 
of lysosomal sphingomyelinase which leads to increased accumulation 
of the phospholipid sphingomyelin in the spleen as well as other 
tissues; along with this, cholesterol, cholesterol ester, total phos-
pholipids and bis-(mono-acylglyceryl) phosphate are also increased 
above the normal range (Rao & Spence, 1977). 
Phospholipid Composition 
The major phospholipids in fibroblasts were sphingomyelin, 
phosphatidylcholine, phosphatidylserine, phosphatidylinositol and 
phosphatidylethanolamine as represented in Table 10. As compared 
with normal infant fibroblasts, there seemed to be somewhat decreased 
amounts of phosphatidylcholine in type 1 cells. Type 2 cells possibly 
had both a decreased amount of sphingomyelin and phosphatidylcholine. 
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Type 3 cells had on the average, decreased amounts of sphingomyelin. 
With respect to normal adult cells, type 1 adult cells exhibited a 
variability of data. AdG 119a seemed to have decreased amounts of 
sphingomyelin and phosphatidylcholine; whereas, there was no difference 
in the phospholipid content of AdG 1470 as compared with normal adult 
cells. 
The decrease in sphingomyelin, phosphatidylcholine and cho-
lesterol ester of Gaucher cells could possibly be due to the fact 
that since there is deficiency of the lysosomal enzyme S-glucosidase 
in Gaucher diseased fibroblasts, there may be a compensatory increase 
in the other lysosomal enzymes such as sphingomyelinase, phospholipases 
and cholesterol esterase. It has been suggested by Rappeport and 
Ginns (1984) and Besley and Moss (1984) that there is an increase in 
activity of lysosomal sphingomyelinase in the cells of patients with 
Gaucher disease. It is also possible that neutral sphingomyelinases 
(non-lysosomal) could have an increased activity, thereby, leading 
to increased degradation of membrane sphingomyelin. However, Sutrina 
and Chen (1984) have shown that in normal cellular metabolism of plasma 
membrane-associated sphingomyelin, majority of it is hydrolyzed by 
lysosomal sphingomyelinases and a minor fraction is degraded by non-
lysosomal neutral sphingomyelinases. It'is possible, with respect 
to decreased phosphatidylcholine content in Gaucher diseased cells, 
that plasma membrane phospholipases could be altered such as to have 
increased activity. It is also possible that the synthesis of phos-
phatidylcholine in Gaucher cells is inhibited, since there is de-
creased amount of sphingomyelin; and thus, the direct enzyme-mediated 
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transfer of phosphorylcholine from sphingomyelin to diglyceride does 
not occur (Spence et al., 1983). The increased activity in cholesterol 
esterase could be due to the general compensatory increase in enzymes. 
If it is the case that lysosomal sphingomyelinase, phospholipases, 
and cholesterol esterase are relatively increased in Gaucher diseased 
cells this would then imply that there is a tight association between 
S-glucosidase and the aforementioned enzymes. The fact that there 
is also decreased amounts of triglycerides in type 1 Gaucher disease 
could be that there is some type of S-glucosidase isozyme deficiency 
or a presence of a factor which is stimulating the activity of tri-
glycerol lipase. 
Ceramide Composition 
The data obtained that the content of ceramide is virtually 
the same in normal and Gaucher diseased fibroblasts implies that the 
activity of lysosomal ceramidase is probably not altered in diseased 
cells. It is also to be noted that the levels of ceramide could be 
important in cell homeostasis (Kannagi et al., 1982) similar to cho-
lesterol, and thus a constant level has to be established. It seems 
interesting that ceramide, a precursor to all the glycosphingolipids, 
is constant in Gaucher cells; whereas, glycosphingolipids are increased 
in Gaucher cells (Saito & Rosenberg, 1984a). This constant ceramide 
level in Gaucher cells are most likely occurring due to increase syn-
thesis of ceramide from sphingosine and fatty acids. Thus, even though 
the catabolic pathway of glucosylceramide is decreased, the anabolic 
starting substrate, ceramide, is tightly controlled. 
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Effects of Monesin 
The finding that monensin treated normal cells give rise to 
decreased cholesterol ester and phosphatidylcholine leads one to sus-
pect that monensin could serve as a chemical modifier which gives 
rise to effects similar to Gaucher disease. This is since monensin 
leads to increased glucosylceramide (Saito et al., 1984) and decreased 
cholesterol ester and phosphatidylcholine in normal fibroblasts. 
These lipid abnormalities do not arise from increased lysosomal enzyme 
activities since it is believed that lysosomal functions are inhibited 
by monensin by increased pH (Tartakoff, 1983). It is possible that 
the activity of acyl coenzyme A:cholesterol 0-acyltransferase (ACAT), 
which catalyzes the formation of cholesterol ester from cholesterol 
and fatty acyl coenzyme A (Chang & Doolittle, 1983), is decreased. 
This then would lead to decreased cholesterol ester and increased 
fatty acids. The (3H) acetate labeling data agrees well with the 
decreased ACAT activity hypothesis. The increased incorporation of 
labeled acetate in cholesterol possibly implies that the activity of 
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which leads 
to increased cholesterol synthesis in the cells (Chang, 1983), is 
increased. Also, other lipids had increased label incorporation pos-
sibly due to stimulation of other microsomal enzymes. 
In relation to decreased phosphatidylcholine content and in-
creased label in this phospholipid, it is possible that monensin, 
which is a cationophore increasing sodium levels in fibroblasts and 
possibly calcium levels, increases activity of membrane-bound phospho-
lipases and, thus, increased phospholipid degradation occurs. This 
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is similar to accelerated phospholipid degradation, which occurs in 
ischemic liver disease due to increased activity of membrane-bound 
phosphalipases activated by Ca2+ increase (Chien et al., 1978). The 
increased incorporation of (3H) acetate label into phospholipids could 
be possible ifmonensin induces microsomal enzyme activity. The pos-
sible reason for increased phosphatidylserine content in monesin 
treated cells could be that the activity of microsomal phosphatidyl-
ethanolamine serine transferase, which catalyzes a calciwn-dependent 
exchange between L-serine and the ethanolamine moiety or phosphatidyl-
ethanolamine (Esko & Raetz, 1983), increases considerably. The rel-
ative stability of ceramide with respect to monesin treatment again 
implies that even though glucosylceramide and higher glycosphingolipids 
are increased, the starting substrate is highly regulated. 
Fatty Acid Composition 
Not only are there differences observed in the quantity of 
neutral lipids and phospholipids in Gaucher disease, but there are 
some differences in the fatty acid components of phospholipids, espec-
ially sphingomyelin, and cholesterol ester. It has been shown by 
Kudoh et al. (1983) that if [stearoyl-1-14c] sphingomyelin is intro-
duced into normal cultured skin fibroblasts, it is degraded in lyso-
somes to [l4C] stearoyl-sphingosine and [l4C] stearic acid. This free 
fatty acid then enters a fatty acid pool for synthesis of the major 
lipids found in cultured skin fibroblasts. These lipids are identified 
to be phospholipids, including phosphatidylcholine and sphingomyelin, 
cholesterol ester, ceramide, and the ganglioside GM3 (Kudoh & Wenger, 
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1982). It has been shown by Warren et al. (1976) that Gaucher cells 
glucosylceramide fatty acids have an increase in C16:0 and ClB:O and 
a decrease in C20:0 and C22:0. From this, it is possible that cera-
mide, phospholipids, and cholesterol ester in cultured skin fibroblasts 
utilize fatty acids from a common pool; and when the pool is depleted, 
such as in Gaucher disease where more fatty acid are used up to main-
tain a normal level of ceramide and an increased quantity of glyco-
sphingolipids, there will be alteration in fatty acid composition of 
related lipids. The association of abnormalities in glycosphingolipid, 
sphingomyelin and cholesterol ester fatty acids could be summarized 
diagrammatically as follows: 
Phospholipids 
Tl Sphingosine 
Fatty Acid \I '> Ceramide ( "' 
Cholesterol~ 1 T 1 T a 
Cholesterol Ester Sphingomyelin 
). GlcCer( ) Higher 
Glyco-
sphingo-
lipids 
In normal fibroblasts, glucosylceramide is catabolised in a normal 
fashion (pathway a) and thus enough fatty acid is available in the 
"pool" for incorporation into other lipids. However, in contrast, 
Gaucher diseased fibroblasts have decreased catabolism of glucosylcer-
amide and thus the fatty acid pool is disturbed, leading to alterations 
in glucosylceramide, sphingomyelin, cholesterol ester and phospholipid 
fatty acid composition. As a further study, it would therefore be 
useful to study fatty acid metabolism in normal and Gaucher diseased 
cultured skin fibroblasts. 
The finding that the cholesterol ester in Gaucher fibroblasts 
do not have the unsaturated C24 fatty acid implies, again, that the 
metabolism of fatty acids is different from that of normal cells. 
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This fatty acid was not observed by Goldstein et al. (1975) in normal 
cultured skin fibroblasts. The only C24 unsaturated fatty acid in 
cholesterol ester has been identified as C24:4 in pork testis by Holman 
and Hofstetter (1965). Thus, it is possible that normal fibroblasts 
have the ability to synthesize C24:4; whereas, Gaucher cells cannot 
synthesize this polyunsaturated fatty acid. 
CHAPTER VI 
SUMMARY 
Membrane fluidity measurements, via steady-state fluorescence 
anisotropy of l,6-diphenyl-1,3,5-hexatriene, were performed on cultured 
human skin fibroblasts from normal and hereditary lysosomal S-gluco-
sidase deficient (Gaucher disease) subjects. At 25°C, type 2 and 
type 3 neuronopathic Gaucher diseased fibroblasts displayed decreased 
membrane fluidity as compared with normal fibroblasts. Type 1 non-
neuronopathic Gaucher cells exhibited variability. Of the three cell 
lines with the type 1 (non-neuronopathic) variety of Gaucher disease, 
only one had decreased membrane fluidity as compared with normal fibro-
blasts. Abnormality in membrane fluidity of the diseased cells was 
correlated with an increase in cholesterol/phospholipid and choles-
terol/sphingomyelin ratios. 
Temperature scan studies of fluorescence anisotropy, between 
4-40°C, on normal and Gaucher diseased fibroblasts gave the same re-
sults as at 25°C. From the temperature scans, Arrhenius plots were 
constructed to determine bulk lipid phase transitions. As could be 
determined from the Arrhenius plots, there were no phase transitions 
detectable over this range in either normal or Gaucher diseased fibro-
blast membranes. 
Neutral lipid, phospholipid and ceramide composition of normal 
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and Gaucher diseased fibroblasts were determined. The major neutral 
lipids were observed to be cholesterol, free fatty acid, triglyceride 
and cholesterol ester. Types 1, 2 and 3 Gaucher diseased fibroblasts 
exhibited a significant decrease in cholesterol ester as compared 
with appropriate controls. Type 1 Gaucher cells also had a lower 
content of triglyceride. Analysis of the fatty acids in cholesterol 
esters of normal and Gaucher diseased cells was performed, and it 
was determined that there was a major difference between the normal 
and the diseased cells. 
The major phospholipids of cultured skin fibroblasts were 
sphingomyelin, phosphatidylcholine, phosphatidylserine, phosphatidyl-
inositol and phosphatidylethanolamine. As compared with normal infant 
cells, there seemed to be a decreased content of phosphatidylcholine 
in type 1 Gaucher cells and, in type 2 Gaucher cells, possibly a de-
creased amount of sphingomyelin and phosphatidylcholine. Type 3 
Gaucher cells had a remarkably decreased amount of sphingomyelin. 
Type 1 adult Gaucher cells exhibited variability. Fatty acid analysis 
of individual phospholipids were also performed, and it was determined 
that there was a significant difference in fatty acid composition of 
diseased cells--especiallly sphingomyelin. The content of ceramide 
was virtually the same in normal and Gaucher diseased fibroblasts. 
Normal cultured skin fibroblasts were treated with the car-
boxylic monovalent cationophore monensin to determine its effect on 
neutral lipid, phospholipid and ceramide composition. Treatment with 
monensin decreased the amount of cholesterol ester and phosphatidyl-
choline, and increased the content of free fatty acid and phosphatidyl-
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serine. When the cells were also labeled with [3H] acetate, there 
was increased incorporation of the label into all lipids except into 
cholesterol ester, where it was decreased, and sphingomyelin and 
ceramide, where the incorporation was relatively constant. The pattern 
due to monensin treatment seems to be similar to that observed in 
Gaucher disease. 
The findings that membrane fluidity and various lipids, inclu-
ding glycosphingolipids, are altered in Gaucher disease indicates that 
even though there is hereditary deficiency of only one lysosomal en-
zyme, 8-glucosidase, this leads to more generalized membrane effects. 
These pronounced metabolic effects are seen in altered membrane fluid-
ity and neutral lipid, phospholipid and fatty acid composition of 
Gaucher diseased fibroblasts. 
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